Loading [MathJax]/jax/output/SVG/jax.js
Research article Topical Sections

Molecular docking and dynamics studies show: Phytochemicals from Papaya leaves extracts as potential inhibitors of SARS–CoV–2 proteins targets and TNF–alpha and alpha thrombin human targets for combating COVID-19

  • Tackling COVID-19 requires halting virus proliferation and reducing viral complications in humans. Papaya leaf extract (PLE) is well known for its ability to inhibit numerous viral replications in vitro and in vivo and reduce viral complications in humans such as thrombocytopenia and cytokine storm. The goal of this research is to evaluate the possible use of papaya leaf extract as a multifaceted antiviral and potential therapy for COVID-19 using an in-silico docking followed by a 100 ns molecular dynamics simulation (MDS) approach. The targeted proteins are the SARS-CoV-2's proteins such as the nucleocapsid, main protease (MPro), RNA-dependent RNA polymerase (RdRP), spike protein (Wuhan, Delta, and Omicron variants) and human TNF-alpha and alpha-thrombin protein targets. Several compounds from PLE such as protodioscin, clitorin, glycyrrhizic acid, manghaslin, kaempferol–3–(2g–glucosylrutinoside), rutin, isoquercetrin and acacic acid were found to exhibit strong binding to these targets. The free energies of binding (Autodock) with protodioscin, the best PLE compound for nucleocapsid, main protease (MPro), RdRP and spike protein were –13.83, –13.19, –11.62 and –10.77 (Omicron), kcal/mol, respectively, while the TNF-alpha and alpha-thrombin binding free energies were –13.64 and –13.50 kcal/mol, respectively. The calculated inhibition constants for protodioscin were in the nanomolar and picomolar range at 216.34, 27.07, 73.28, and 99.93 pM, respectively, whilst RdRp and spike protein (Omicron) were in the nanomolar range at 3.02 and 12.84 nM, respectively. Protodioscin interacted with key residues of all protein targets. The binding affinity poses were confirmed by molecular dynamics simulation. Analysis of the binding affinities calculated employing the molecular mechanics-Poisson–Boltzmann surface area (MM-PBSA) shows favorable interaction between protodioscin, and all targets based on total binding-free energies corroborating the Autodock's docking results. In conclusion, compounds from PLE, especially protodioscin have good potentials in combating COVID-19.

    Citation: Mohd Shukri Abd Shukor, Mohd Yunus Abd Shukor. Molecular docking and dynamics studies show: Phytochemicals from Papaya leaves extracts as potential inhibitors of SARS–CoV–2 proteins targets and TNF–alpha and alpha thrombin human targets for combating COVID-19[J]. AIMS Molecular Science, 2023, 10(3): 213-262. doi: 10.3934/molsci.2023015

    Related Papers:

    [1] Soumya Kanti Hota, Santanu Kumar Ghosh, Biswajit Sarkar . A solution to the transportation hazard problem in a supply chain with an unreliable manufacturer. AIMS Environmental Science, 2022, 9(3): 354-380. doi: 10.3934/environsci.2022023
    [2] Richi Singh, Dharmendra Yadav, S.R. Singh, Ashok Kumar, Biswajit Sarkar . Reduction of carbon emissions under sustainable supply chain management with uncertain human learning. AIMS Environmental Science, 2023, 10(4): 559-592. doi: 10.3934/environsci.2023032
    [3] Mowmita Mishra, Santanu Kumar Ghosh, Biswajit Sarkar . Maintaining energy efficiencies and reducing carbon emissions under a sustainable supply chain management. AIMS Environmental Science, 2022, 9(5): 603-635. doi: 10.3934/environsci.2022036
    [4] Bijoy Kumar Shaw, Isha Sangal, Biswajit Sarkar . Reduction of greenhouse gas emissions in an imperfect production process under breakdown consideration. AIMS Environmental Science, 2022, 9(5): 658-691. doi: 10.3934/environsci.2022038
    [5] Mehrbakhsh Nilashi, Rabab Ali Abumalloh, Hossein Ahmadi, Mesfer Alrizq, Hamad Abosaq, Abdullah Alghamdi, Murtaza Farooque, Syed Salman Mahmood . Using DEMATEL, clustering, and fuzzy logic for supply chain evaluation of electric vehicles: A SCOR model. AIMS Environmental Science, 2024, 11(2): 129-156. doi: 10.3934/environsci.2024008
    [6] Sanjeev Sharma, Vinay Kandpal, Tanupriya Choudhury, Ernesto D.R. Santibanez Gonzalez, Naveen Agarwal . Assessment of the implications of energy-efficient technologies on the environmental sustainability of rail operation. AIMS Environmental Science, 2023, 10(5): 709-731. doi: 10.3934/environsci.2023039
    [7] Subhash Kumar, Ashok Kumar, Rekha Guchhait, Biswajit Sarkar . An environmental decision support system for manufacturer-retailer within a closed-loop supply chain management using remanufacturing. AIMS Environmental Science, 2023, 10(5): 644-676. doi: 10.3934/environsci.2023036
    [8] Ashish Kumar Mondal, Sarla Pareek, Biswajit Sarkar . The impact of shared-production and remanufacturing within a multi-product-based flexible production system. AIMS Environmental Science, 2023, 10(2): 267-286. doi: 10.3934/environsci.2023016
    [9] Seiran Haghgoo, Jamil Amanollahi, Barzan Bahrami Kamangar, Shahryar Sorooshian . Decision models enhancing environmental flow sustainability: A strategic approach to water resource management. AIMS Environmental Science, 2024, 11(6): 900-917. doi: 10.3934/environsci.2024045
    [10] Hsin-Yao Hsu, Ming-Hon Hwang, Yuan-Shyi Peter Chiu . Development of a strategic framework for sustainable supply chain management. AIMS Environmental Science, 2021, 8(6): 532-552. doi: 10.3934/environsci.2021034
  • Tackling COVID-19 requires halting virus proliferation and reducing viral complications in humans. Papaya leaf extract (PLE) is well known for its ability to inhibit numerous viral replications in vitro and in vivo and reduce viral complications in humans such as thrombocytopenia and cytokine storm. The goal of this research is to evaluate the possible use of papaya leaf extract as a multifaceted antiviral and potential therapy for COVID-19 using an in-silico docking followed by a 100 ns molecular dynamics simulation (MDS) approach. The targeted proteins are the SARS-CoV-2's proteins such as the nucleocapsid, main protease (MPro), RNA-dependent RNA polymerase (RdRP), spike protein (Wuhan, Delta, and Omicron variants) and human TNF-alpha and alpha-thrombin protein targets. Several compounds from PLE such as protodioscin, clitorin, glycyrrhizic acid, manghaslin, kaempferol–3–(2g–glucosylrutinoside), rutin, isoquercetrin and acacic acid were found to exhibit strong binding to these targets. The free energies of binding (Autodock) with protodioscin, the best PLE compound for nucleocapsid, main protease (MPro), RdRP and spike protein were –13.83, –13.19, –11.62 and –10.77 (Omicron), kcal/mol, respectively, while the TNF-alpha and alpha-thrombin binding free energies were –13.64 and –13.50 kcal/mol, respectively. The calculated inhibition constants for protodioscin were in the nanomolar and picomolar range at 216.34, 27.07, 73.28, and 99.93 pM, respectively, whilst RdRp and spike protein (Omicron) were in the nanomolar range at 3.02 and 12.84 nM, respectively. Protodioscin interacted with key residues of all protein targets. The binding affinity poses were confirmed by molecular dynamics simulation. Analysis of the binding affinities calculated employing the molecular mechanics-Poisson–Boltzmann surface area (MM-PBSA) shows favorable interaction between protodioscin, and all targets based on total binding-free energies corroborating the Autodock's docking results. In conclusion, compounds from PLE, especially protodioscin have good potentials in combating COVID-19.



    1) Technological growth

    To confront globalization, expanded item complexity, and increased demand, it is essential for companies to take up up-gradation in technology to convert their supply chain (SC) from a traditional one to a smart one. Utilizing Radio-Frequency Identifier (RFID) and a fast web network, forward-thinking companies can collect information at each checkpoint, from the status of crude materials stream to the location and condition of wrapped-up products. Artificial intelligence (AI), machine learning, and progressed autonomation convey experiences that advance efficiencies by making on-the-fly route changes to quicken item conveyance. Many researchers in modern SC models apply these progressed technologies. For illustration, numerous firms are using the "internet of things" (IoT) to offer proactive support for maintenance that ensures the service for the product. In the competitive market, up-gradation of the production house and warehouse is essential; otherwise, that industry must be losing its place in the market [1]. Using innovative technology like drone transportation, drone inspection, RFID tag, RFID scanner, RFID signal receiver, Bar code reader (BCR), QR code reader, Computers, Close circuit camera system, WIFI and networking, conveyor belts, air conditioning, a traditional manufacturing house, and warehouse can be made a smart one [2]. Innovative technology can prevent the inaccurate demand problem due to unreliable retailers in his study [3]. Recently, Tseng et al. [4] discussed the data analysis regarding the challenges and changes for industry 4.0 regarding technological growth.

    2) Flexible production rate

    A flexible manufacturing system (FMS) is a planned production strategy to effectively adjust to changes in the quality and amount of the item being produced. In general, manufacturers favor making items with culminating quality. But quality depends on various facts such as the crude material, breakdown of machines, the inefficiency of skilled labor, and long-run production system. A production system may create imperfect things ceaselessly for these components, which should be settled to stay within the competitive market. Along with the technological growth, by applying a flexible production rate, the industry has mechanically up-grade the traditional production system to an intelligent production system [5]. Flexible production can help to improve the quality of the produced defective product even in a out-of-control stage of the production system [6]. For that, the flexible production rate is also imperative for an SC.

    3) Smart produce

    Industry 4.0 has driven world-view shifts and changes for arranging and upgrading production processes. This significant change influences not the integration of the technical and physical situations but, most critically, the connections between customers and the production house. To effectively grasp this up-gradation and stand up to the various challenges, production houses ought to adapt to the requirements for innovative technical progression and give feasible preparation and instruction for their workforce. The industry directors ought to take under consideration the human-in-the-loop for this technical up-gradation challenges and also consider a 3I (Interaction, Intellect, and Interface) angle for manufacturing plants to extend the habitation of smart production using technologies [7]. Smart produce strategy points to include information on production technologies, explains suitable ways for customers to know the insights of technologies used for a production system, and targets the collaboration between customers and the production system. Again for an unreliable production system, it is essential for smart production to upgrade the traditional production into a smart one by implementing innovative technology [8], which helps to prevent the shortage problem due to the unreliability of the production system. In a smart production system, the inspection process can be controlled by automated machines which remove the defective items produced by the production house and move those items for remanufacturing [9]. For all the above reasons, smart production is essential for an SC.

    4) Transportation policy

    Transportation is the major fundamental component of an SC. It includes the conveyance of items from the beginning to the conclusion of an SC. It involves shipping an item from a provider to a client or a warehouse through roadways, railways, pipelines, airways, or waterways. Transportation is habitually utilized within the SC facilitation. Implementation of an efficient transportation strategy is essential for an SC to make it successful. A suitable transportation strategy may be utilized to diminish the SC's total cost, upgrade client service, smooth shipments within the SC, synchronize with smart technologies of the SC, give more flexibility in the SC, bypass geological confinements, and boost the economy of the company. Therefore transportation policies should implement in SC for reducing transportation time [10], transportation cost [11], take care about social commitment and logistic challenges [12]. Some authors applied strategies like single-setup-single-delivery (SSSD) policy [13], single-setup-multi-delivery (SSMD) [14], single-setup-multi-unequal-delivery (SSMUD) [15], single-setup-multi-unequal-increasing-delivery (SSMUID) [16] for smooth functioning of the transportation system.

    5) Unreliability

    Nowadays, an increasing headache for industry managers is the unreliability of players. In a traditional SC, players are honest and do not hide any information from other players. Still, in today's environment, players of an SC are opportunistic and hide information from other players. As a result, the industry lost the demand for its product, lost its reputation, lost revenue, and got in trouble for smooth conduction. So, it's a challenge for the industry managers to solve the unreliability player problem and improve the performance of the SC. The unreliable player may be the retailer [17], supplier [18] may be the manufacturer [19] or maybe the buyer [13]. The unreliable manufacturers often hide the number of manufactured products from the retailers and produce less than the retailer's ordered quantity. Because of this reason, a shortage arose, which caused lost sales (some are backlogged due to the good reputation of the retailers and the product). Also, the unreliable retailer hides actual sales information from the manufacturer, making it difficult to estimate the manufacturer accurately. The raw material quality of the manufacturer is so good. Thus, instead of the unreliability of the manufacturer, the retailers don't want to lose that manufacturer.

    This study's main objectives are to solve the retailer's shortage problem due to the manufacturer's unreliability and inaccurate estimation problem of the manufacturer due to unreliability of the retailers by using smart warehouses and implementing technological development for both players. Thus in this study, the technological development is conducted using smart technologies like RFID readers and tags, CCTV, web, and LAN.

    Due to a smart manufacturing system, a flexible production system is required, which reduces the manufacturing cost of the manufacturer and increases labor efficiency, improves machine productivity, upgrades the system's reliability, enhances the quality, and shorter lead times, boosts production.

    In the traditional SC model, it is assumed that the produced items are always of good quality. But in reality, due to the long-run process and other factors, the production system may go to an out-of-control stage for which continuously defective items are produced. By smooth produce, minimize the number of faulty items build in an imperfect production system.

    Take into account the improvement of environmental sustainability, implement a suitable transportation strategy (SSMUID policy) to reduce the total cost of the SC and solve the shortage problem for the retailer.

    Finally, with proper examples and representation, minimize the total cost of the SC with suitable optimization techniques and explain the optimization. A sketch of a smart warehouse is shown in Figure 1. A brief introduction is described in Section 1 whereas some previous work on this field is illustrated in Section 2. In Section 3, all notations and assumptions used throughout the study are given, and the problem is explained. The model is formulated in Section 4. The solution process of the model is interpreted in Section 5 and the model is analyzed with a numerical example and sensitivity analysis. The conclusion, future extensions of the model, and the managerial insights are explored in Section 8 and Section 7.

    Figure 1.  Smart Production house.

    An SC is a network among various players like manufacturers, suppliers, retailers, buyers, transporters, and third-party logistics to manufacture and encase a specific item to the final player, including different actions, persons, organizations, particulars, and assets. It deals with the flow of products and services and covers the whole system that converts the raw product into final material. Several SC management models have started from Scarf [20] to the date where Pal and Adhikari [21] gave a recent study that described the hazards problem of machines in a sustainable SC with multi-retailers, variable demand, flexible production rate and. A multi-echelon stochastic sustainable closed-loop SC with Multi-objective optimization for multi-echelon, multi-product was recently discussed by Elfarouk et al. [22].

    In the present marketing trends, a customer wants quick and on-time delivery. In the traditional SC, players of an SC are honest and provide appropriate information. But in today's marketing environment, players are opportunistic and hide sales information from the other players to increase their profits. The industry managers cannot provide good customer service for this kind of unreliability of players and cannot ensure the smooth functioning of the SC. Companies adopt intelligent technologies and upgrade their traditional production house into a smart production houses for that purpose. Also, transportation plays a vital role in an SC. Delivery of the whole produced unit to the retailer in a cycle is not beneficial to the industry as it increases the holding cost of the retailer. So to reduce the retailer's holding cost, the single setup multiple unequal increasing delivery policy, which is applied in this study, is necessary.

    Chen et al. [23] studied unreliable channels whereas Entezaminia et al. [24] discussed about unreliable manufacturing system and Romero-Silva et al. [25] unequal processing time, merging line performance. In the study of Sardar et al. [3], and Sardar and Sarkar [26] the retailer of the SC is unreliable and hide sales information from the manufacturer, whereas in the study of Guchhait et al. [13], buyers are not reliable. Uncertain cost of the product is considered in the study of Sarkar et al. [27], and Hota et al. [16] consider unreliable manufacturer in their study. Park and Lee [28] considered multiple unreliable suppliers. Recently, Hota et al. [57] solved a problem due to transportation hazards in an SC with an unreliable manufacturer. But none of these authors considered applying smart technology in an SC with unreliable manufacturers who adopt the SSMUID policy. So there is a gap in research that is fulfilled in this study.

    To upgrade a traditional production house into a smart production house, one of the essential items needed is RFID. RFID gives an accurate estimation of the number of produced items and which helps to prevent shortage problems. The reusable RFID tags are scanned automatically by an RFID scanner, and the industrial managers get the accurate number of produced items through online mode. The implementation of the RFID technology to control the unreliability problem and maximize the SCM's profit was described by Guchhait et al. [13]. In contrast, Ullah and Sarkar [29] applied RFID to increase the recycling rate of electronic products. Sardar et al. [3] used RFID to follow the movement of the product, and RFID was used by Sardar and Sarkar [26] in shops to get information about the exact amount of demand for the product among customers. None of these authors applied RFID to a production house to get the accurate number of produced items. In this study, a technological growth cost is used to install RFID scanners, RFID tags, internet, and other intelligent technologies to upgrade the production house into a smart one and prevent inaccurate estimation of produced items due to unreliability of the manufacturer.

    Dalenogare et al. [30], and Wang et al. [31] about the technologies of industry 4.0, which can be used as a part of a smart manufacturing system. Chen et al. [32] gave a brief discussion about the smart production house, while Different types of technologies applied for upgrading a production house into a smart one in industry 4.0 were proposed by Frank et al. [1]. Bueno et al. [2] explained how smart production houses improved the technologies of industry 4.0 to reach smart production planning and control. In contrast, Bueno et al. [2] explained how industries 4.0 technologies assist the control process and production planning by using artificial intelligence to enhance the production activity. In the smart production system of Dey et al. [33] an automated system was installed to deeply inspect the produced items and reject the defective items without any error. Bhuniya et al. [34] smart production system manufactured smart products at the least possible cost with saving energy. The study by Sarkar et al. [5] deals with how a smart production system can control the carbon footprint, obtaining the net present value of products for the four sub-systems associated with the logistics system. Sarkar et al. [9] got the net current worth of the product and controlled the carbon footprint by a smart production system. Sarkar and Sarkar [35] optimizes the ramification of production size, production rate, and safety stocks underutilization of energy in a smart production system. But none of them considered transportation policies in their models, which plays an essential role in SCM. This study fulfills this research gap by applying a suitable transportation policy named SSMUID policy.

    The holding cost of the Retailer is practically greater than the holding cost of the manufacturer because the production houses are usually situated in rural areas. In contrast, the retail houses are situated in towns or cities or metro cities. So transporting the whole manufactured amount in a single lot, the SSSD (single-setup-single-delivery) policy is not scientific, increasing the manufacturer's holding cost. Goyal [36] upgrades the SSSD policy by dividing the delivery of the whole produced quantity into a finite number of lots called SSMD (single-setup-multiple-delivery) policy. Some authors considered that the lot sizes of each lot are equal [14], but the demand for the product may not always be fixed, so delivering an equal amount in each lot may not be scientific. Hoque [37] considered equal/unequal shipment size in his study but Hariga et al. [38] consider only unequal shipment size in their studies. Sarkar et al. [15] introduced the SSMUD (single-setup-multiple-unequal-deliver) policy in which the lot sizes of each lot differed. Hota et al. [16] introduced the SSMUID (single-setup-multiple-unequal-increasing) policy in which the lot size of each lot is a multiple of the previous by a fixed multiplier for items of increasing demand. But none of the authors consider SSMUID policy in a smart SC with unreliable players.

    Based on the above discussion following research questions are raised:

    ● In the literature, several SC models were discussed about reliable player [39,40], however unreliable players where manufacturer and retailer both are unreliable still a questionable research direction. In this research, we try to fulfill the research gap.

    ● There were many SC model developed under the consideration of different transportation policy, like SSSD [41], SSMD [42], however SSMUID transportation policy in an unreliable SC system is very rare [16]. Thus in this research study, an attempt is made to fill this gap.

    ● Many SC models were constructed under the consideration of distribution robust approach [43]. But utilization of some smart technology in the SC model along with the metaheuristic solution approach is still a big research gap in the SC research direction. A pioneering attempt is made in this study to fill this gap.

    Finally, the research contribution can be summaries as the shortage problem of a smart SC with a single unreliable manufacturer and unreliable multi retailers is solved in the study by applying innovative technology and SSMUID policy. For smooth conduction of the SC, a smart product house, variable transportation cost, material-dependent product cost, and transportation are applied in this study. In contrast, electricity consumption-dependent carbon emission costs are involved for enhanced environmental sustainability. Since the mean and the standard deviation of the random variable associated with the lead time demand are unknown, a robust distribution approach is applied to solve the model. For the presence of multiple retailers, a metaheuristic solution approach is utilized, and the model is solved numerically by the two popular methods, GA and PSO. Also, the result of the two methods are compared to find the most beneficial method, and four special cases are explained for the reality of the study. A summary of the literature is given in Table 1.

    Table 1.  Authors contribution table.
    author(s) unreliable ST TPS PR CDO OT
    Sarkar et al. [15] NC NC SSMUD NC TP CL
    Park and Lee [28] supplier NC SSSD NC NC CL
    Majumder et al. [44] NC NC SSMD NC TP CL
    Tang et al. [45] NC NC SSSD NC TP & EC CL
    Bhuniya et al. [46] NC Considered SSSD flexible NC CL
    Guchhait et al. [13] buyer Considered NC NC NC CL
    Mishra et al. [47] NC Considered SSMD NC TP CL
    Sardar and Sarkar[26] retailer Considered NC NC NC CL
    Sardar et al. [3] retailer Considered NC NC NC CL
    Chen et al. [23] channel Considered NC NC NC MT
    Dey et al. [33] NC Considered SSSD NC NC CL
    This model manufacturer Considered SSMUID flexible TP GA &
    and retailer PSO
    Note: NC - Not considered, ST - smart technology, TP - transportation, TPS - transportation strategy, EC - electric consumption, PR - production rate, CDO - carbon emission cost depends on, OT - optimization technique, CL - classical optimization technique, MT - Monte Carto test and probability.

     | Show Table
    DownLoad: CSV

    Decision variables
    sj 1st lot size for each retailer (unit)
    λ increasing rate for each retailer
    n number of lots
    dr distance between two RFID reader (m)
    ζ1,ζ2 Lagrangian multipliers
    θ designed reliability defined as θ=NumberoffailuresTotalunitsofusedhours and θ[θmin,θmax]
    πxj backorder price discount for each retailer ($/unit)
    Parameters
    q number of retailers
    S total lot size of 1st lot, that is S=qj=1Sj (unit)
    Dj demand for the jth retailer (unit)
    D total demand, that is D=qj=1Dj (unit)
    Qj ordered quantity of the jth retailer (unit)
    Q total ordered quantity, that is Q=qj=1Qj (unit)
    αj fraction of ordered quantity manufactured by the manufacturer for the jth retailer
    α fraction of total ordered quantity manufactured
    by the manufacturer for the retailers α=qj=1αj
    P production rate (unit)
    CP unit production cost ($/unit)
    Cm material cost ($/unit)
    A fixed cost of manufacturing ($)
    B resource cost ($/unit)
    θmax maximum value of θ
    θmin minimum value of θ
    k a constant representing the difficulties in the increasing reliability
    τ tool cost for technological up-gradation($/tool)
    Υ total inventory (unit)
    ΥA average inventory (unit)
    η1 number of items in each box (unit)
    Crft cost of RFID tag ($ /unit)
    l length of the inspection area (m)
    b breadth of the inspection area (m)
    St transmission radius of type 1 reader (m)
    Ss sensing radius of type 1 reader (m)
    d distance between two RFID readers (m)
    ϕ the threshold parameter (0<ϕ<1)
    ρ decay parameter for sensing
    Cset setup cost of the manufacturer ($/unit)
    η2 the area covered by a closed circuit camera (m2)
    Ccc cost of CC camera ($/unit)
    Cwr cost of WIFI router ($/unit)
    Cot other technological growth cost ($/m2)
    Cset setup cost of manufacturer ($/unit)
    Chm holding cost of the manufacturer ($/unit)
    Cftm fixed transportation cost of the manufacturer ($/unit)
    Cfcm fixed carbon emission cost of the manufacturer ($/unit)
    Cvtm variable transportation cost of the manufacturer ($/unit)
    Cvcm variable carbon emission cost of the manufacturer ($/unit)
    g0j amount of the fuel consumption for the return trip from jth retailer to the manufacture that is fuel consumption of the unloaded (empty)
    vehicle when returning from jth retailer (unit)
    g1j the unit fuel consumption factor when the transportation vehicle is loaded with goods for jth retailer (per unit of goods) (unit)
    ω1 carbon emission factors for fuel
    ω2 carbon emission factors for electricity
    w0 fixed electricity consumption per unit time per unit storage (unit)
    w1 variable electricity consumption per unit time per unit storage (unit)
    Aj ordering cost of jth retailer ($/unit)
    rj reorder points of the jth retailers
    kj safety stock of the jth retailers (unit)
    π0j marginal profit per unit of jth retailer($/unit)
    βj backorder ration of jth customer
    β0j upper bound of the backorder ratio 0<β0j<1
    Lj lead time for jth retailer (days)
    Xj random variable associated with the lead time demand of jth retailer with mean DjLj and stand deviation σjLj

    1. A SC with a single manufacturer, q retailers, and a single type of products are studied ([48]). Both the manufacturer and retailers are unreliable. The production house and warehouse are equipped with the latest technologies and upgraded from a traditional one to a smart one.

    2. The manufacturer is unreliable who produced αQ unit of items Q=(Q1,Q2,...,Qq) is a row vector the ordered quantity of the two retailers and α=(α1,α2,...,αq) is another row vector where 0<αi<1 and αQ=qj=1αjQj ([28]).

    3. The manufacturer produces αQ quantity at a time that is less than the total order amount. Still, to save the holding costs of the retailer, the manufacturer delivers these products in n lots, and the lot sizes are increased by a multiplier in each lot. For jth retailer the first lot size is sj unit, second lot size is λsj unit, ......, the nth lot size is λn1sj where j=1,2,...,q. Therefore αQ=qj=1[sj+λsj+...+λn1sj]=λn1λ1qj=1sj=λn1λ1S ([16]).

    4. To upgrade the traditional warehouses into smart warehouses and solve the unreliable retailer problem by proper inspection, the manufacturer initiated a technological up-gradation in the warehouses of the retailer and production house. The costs associated with this technology include installing and maintaining RFID tags and scanners, CCTV, WIFI and internet, and other expenses related to the technical up gradation. In the smart manufacturing house, all RFID scanners [13], RFID tag, CC Camera, and WIFI router are symmetric. The lenses of the CC cameras are rectangular.

    5. A flexible production rate with production cost depending on smart tool cost is applied to upgrade the traditional manufacturing house into a smart manufacturing house. The unit production cost CP=Cm+CDP+τP where CD=A+Bek(θmaxθθθmin); θ is the designed reliability defined as θ=NumberoffailuresTotalunitsofusedhours and a θ[θmin,θmax], A is the fixed cost of manufacturing, B is the resource cost when θ=θmax, k is a constant representing the difficulties in the increasing reliability, τ is the tool cost and Cm is the material cost ([46]).

    q unreliable retailers orders Q=(Q1,Q2,...,Qq) units of products to the unreliable manufacturer, and the manufacturer produces αQ quantity of units (Figure 2). Therefore, shortages arise, shortages are partially backlogged and reorder points of the retailers are variables.

    Figure 2.  This model.

    The manufacturer uses a smart manufacturing house and a technological growth designed to set up the smart manufacturing house. The retailers have a smart warehouse, and the inventory level goes down due to demand. Due to the unreliability of the manufacturer, the retailers receive less quantity of items of the ordered quantity. The lead time demand is found as a random variable and the expected shortages of the jth retailer is E(Xjrj)+ where rj are the re-order points of the jth retailer. Thus, the number of backorder and lost sales of jth retailer are βjE(Xjrj)+ and qj=1(1βj)E(Xjrj)+, respectively, where 0<βj<1,j=1,2,...,q are rate of backorders of the jth retailers.

    The inventory position of the manufacturer is described in Figure 3. By Assumption 2, the number of production cycle is qj=1DjαQ, i.e. Dλn1λ1S,.

    Figure 3.  Inventory level of manufacturer and retailer.

    The manufacturer introduces smart technology like RFID tags, RFID scanners, CCTV, air conditioning, and others to make the smart manufacturing house. Thus, there are some extra costs due to this up-gradation.

    The average inventory of the manufacturer is

    ΥA=[SP(1n2)+(λn1λ112λn+1λ+1)qj=1sjDj]D (4.1)

    The costs of the manufacturer are given below:

    As Assumption ???, to prevent the unreliability of the retailer, the manufacturer installs RFID tags and scanners, CCTV, and internet in warehouses and upgrades them from traditional to smart ones. The total cost for technological growth per cycle is given by

    TGCM = RFID tag cost + RFID scanner cost + CCTV system cost + Internet connectivity cost + Other technological growth cost

    TGCM=DαQαQη1Crft+f(d)+lbη2Ccc+lbCwr+DαQlbCot, (4.2)

    subject to the condition d3(μLog[131ϕ]ρ) and St2Ss.

    See Appendix 9 for a detailed calculation of RFID tag cost, RFID scanner cost, CCTV system cost, Internet connectivity cost, and Other technological growth costs.

    As per assumption 5 the unit production cost CP=[Cm+CDP+τP]αQ. Therefore the production cost of the manufacturer is DαQCP, that is

    D[Cm+A+Bek(θmaxθθθmin)P+τP] (4.3)

    Since the cycle length of the manufacturer is αQD, and the setup cost is Cset, the setup cost of the manufacturer per cycle is given by

    DαQCset

    The average holding inventory as calculated in equation no 4.1 is ΥA, and the manufacturer's holding cost per unit item is Chm. Therefore the holding cost per cycle of the manufacturer is as follows.

    ΥAChm

    Due to the increasing number of transportation besides a fixed carbon emission and transportation cost, consumed fuel-dependent carbon emission and transportation cost and consumed electric-dependent carbon emission cost are considered ([45]). The fixed transportation cost of the manufacturer is

    nqDαQCftm

    The variable transportation cost of the manufacturer is

    DαQ[2nqj=1g0j+λn1λ1qj=1g0jsj]Cvtm

    where g0j is the fuel consumption of the unloaded (empty) vehicle when returning from jth retailer, and g1j is the unit fuel consumption factor when the vehicle is loaded with goods for jth retailer per unit of goods.

    Again the fixed carbon emission cost of the manufacturer is

    nqDαQCfcm

    The variable carbon emission cost has two components, the 1st one is for transportation, and the 2nd one is for electricity consumption in the manufacturing house. In a similar way, the carbon emission cost due to transportation is

    DαQ[2nqj=1g0j+λn1λ1qj=1g1jsj]ω1Cvcm

    and the carbon emission cost for electricity consumption in the warehouse is

    (w0+w1ΥA)ω2Cvcm

    where ω1 and ω2 are carbon emission factors for fuel and electricity and w0,w1 are fixed and variable electricity consumption per time unit for storage. Therefore, the total carbon emission and transportation cost of the manufacturer is [ see Tang et al. [45]]

    nqDαQ[Cftm+Cfcm]+DαQ[2nqj=1g0j+λn1λ1qj=1g1jsj](Cvtm+ω1Cvcm)+(w0+w1ΥA)ω2Cvcm

    Thus the total cost of the manufacturer is

    JTCM(sj,λ,n,d,θ)=DαQαQη1Crft+f(d)+lbη2Ccc+lbCwr+DαQlbCot+D[Cm+A+Bek(θmaxθθθmin)P+τP2]+DαQCset+ΥAChm+nqDαQ[Cftm+Cfcm]+DαQ[2nqj=1g0j+λn1λ1qj=1g1jsj](Cvtm+ω1Cvcm)+(w0+w1ΥA)ω2Cvcm (4.4)

    subject to the condition d3(μLog[131ϕ]ρ) and St2Ss and j=1,2,...,q.

    Figure 3 is the figure of the jth retailer. q retailers of this model has q smart warehouse. The inventory decreases due to demand only. The production batch transported form manufacturer to jth retailer is

    sj+λsj+...+λn1sj=sjλn1λ1 (4.5)

    Thus, according to Sarkar et al. [15] the number of production cycle of jth retailer is given by

    Djsjλn1λ1=Djsjλ1λn1. (4.6)

    Again, from figure 3 the total inventory of the jth retailer is

    12λ2n1λ21s2jDj.

    Thus, the total inventory of retailers is

    12λ2n1λ21qj=1s2jDj. (4.7)

    The ordering cost of the retailer is

    qj=1Djsjλ1λn1Aj (4.8)

    Since the manufacturer is unreliable and delivers less ordered products to the retailer, there must be a shortage. When shortages arise, customers are moved to other retailers to purchase the product and lose sales. But in reality, because of the retailer's good reputation, some of them wait until replenishment of the product. So their backlogging is partial. Retailers offer price discounts πxj for customers to reduce the lost sales. According to Lin [49] total annual stockout cost of the retailers is

    λ1λn1qj=1[Djsj{π0jβ0jπxj+β0j(πxj)2π0j}E(Xjrj)+]

    where βj=β0jπxjπ0j be the backorder rate and β0j be the upper bound of backorder ratio and π0j be the marginal profit per unit of the jth retailer and 0β0j<1, 0πxjπ0j.

    Units of holding items of jth retailer is

    (Djsjλ1λn1)(12λ2n1λ21s2jDj)=12λn+1λ+1sj (4.9)

    for Total holding cost of the retailer is

    qj=1[12λn+1λ+1sj+(rjDjLj)+(1β0jπxjπ0j)E(Xjrj)+]Crh.

    where 0β0j<1, 0πxjπ0j.

    Thus the total cost of the retailer is

    JTCR(sj,λ,πxj)=qj=1Djsjλ1λn1Aj+λ1λn1qj=1[Djsj{π0jβ0jπxj+β0j(πxj)2π0j}E(Xjrj)+]+qj=1[12λn+1λ+1sj+(rjDjLj)+(1β0jπxjπ0j)E(Xjrj)+]Crh, (4.10)

    where j=1,2,...,q and 0β0j<1, 0πxjπ0j.

    The joint total cost of the SC is

    JTSCM(sj,λ,n,d,θ,πxj)=JTCM(sj,λ,n,d,θ)+JTCR(sj,λ,πxj) (4.11)

    subject to the condition d3(μLog[131ϕ]ρ), St2Ss, 0β0j<1, 0πxjπ0j and j=1,2,...,q.

    The Kuhn-Tucker (KT) method is applied to find the optimal result. The manufacturer's cost function constraints are modified and transferred into an unconstrained function by introducing two multipliers ζ1 and ζ2. Again the uncertain demands Di of the retailers are represented by random variables with mean DjLj and standard deviation σjLj. Then according to the lemma of Moon and Choi [50], the shortage amount is

    E(Xjrj)12σjLj(1+k2jkj) (5.1)

    and Rj=DjLj+kjσjLj. Applying the KT-multipliers and

    JTSCM(sj,λ,n,d,θ,kj,πjx)=JTCM(sj,λ,n,d,θ)+JTCR(sj,λ,πjx)=DαQαQη1Crft+f(d)+lbη2Ccc+lbCwr+DαQlbCot+D[Cm+A+Bek(θmaxθθθmin)P+τP2]+DαQCset+ΥAChm+nqDαQ[Cftm+Cfcm]+DαQ[2nqj=1g0j+λn1λ1qj=1g1jsj](Cvtm+ω1Cvcm)+(w0+w1ΥA)ω2Cvcm+qj=1Djsjλ1λn1Aj+λ1λn1qj=1[Djsj{π0jβ0jπxj+β0j(πxj)2π0j}12σjLj(1+k2jkj)]+qj=1[12λn+1λ+1sj+σjLj{kj+12(1β0jπjxπ0j)(1+k2jkj)}]Crh+ζ1[d3(μLog[131ϕ]ρ)]+ζ2(2SsSt)

    where 0β0j<1, 0πxjπ0j.

    Presently, it is essential to illuminate the optimization issue of the cost function with a suitable strategy. In this, the optimization issue could be a mixed-integer nonlinear programming problem. For fathoming these issues, a Real Coded Genetic Algorithm (RCGA) is created for continuous and integer variables. Most probably, GA is the widely applied and most popular algorithm for optimization. The working rule of the implemented RCGA is described in the algorithm given below:

    Step 1: Set the initial values of the parameters of RCGA, bounds of the decision variables, and the values of the cost and other parameters of the problem;

    Step 2: ς0 (where ς represents the number of current iteration/generation);

    Step 3: Initialize the chromosomes of populace P(ς) where P(ς) implies the ς'th stage iteration/generation;

    Step 4: The fitness function P(ς) is to be evaluate for each chromosome of P(ς).

    Step 5: According to the fitness value of each chromosome, Trace out the ideal chromosome from P(ς);

    Step 6: Repeat the steps given below until the optimal condition is satisfied:

    1. increase ς by 1, (ςς+1);

    2. Upgrade the old population to a new one;

    3. Improve the existing population by mutation and crossover operations;

    4. Find the fitness of every chromosome of P(ς);

    5. Find the fittest chromosome;

    6. Find the best chromosome among the current (P(ς)) and previous (P(ς1)) population and save the better value.

    Step 7: Print the best solution;

    Step 8: End

    Various parameters, like population size, probability of crossover, the maximum number of generations, and probability of mutation, are used throughout GA. There's no particular rule for the choice of population size, and however, for a large population size, some problems may arise in GA. Again GA cannot work for a small population size. Also, there is no proper rule for estimating the maximum number of generations. The probability of crossover can't be less than the probability of mutation. The most important task for the smooth running of GA is to design an appropriate chromosome of solutions.

    For more explanation, a flow chart of GA is described in Figure 4.

    Figure 4.  Flow chart of GA.

    Particle Swarm Optimization (PSO) is a population-based worldwide optimization algorithm built on social interaction and personal experience. This calculation is motivated by the social behavior of flocking of birds or schooling of fish. The search strategy of PSO can be summarized as bellow:

    Step 1: Initialize the parameters of PSO and decision variable's upper and lower bounds of the of the problem;

    Step 2: Initialize particles population with random velocity and positions;

    Step 3: Find the particles fitness;

    Step 4: Invigilate the highest fitness locations;

    Step 5: Invigilate the global maximum fitness position;

    Step 6: Update each particle's velocity;

    Step 7: Update each particle's position;

    Step 8: Go to Step 9 if the optimal condition satisfied, otherwise go to step 3;

    Step 9: Print the result;

    Step 10: End

    For more explanation, a flow chart of PSO is described in Figure 5.

    Figure 5.  Flow chart of PSO.

    A numerical example is explained with the following data to demonstrate the proposed study.

    q=3, D1=400 unit, D2=450 unit, D3=105 unit, η1=4 unit, Crft=25 $/unit, St=120 m, Ss=60 m, Crfs1=300 $/unit, Crfs2=200 $/unit, l=300 m, b=300 m, μ=12 m2, ρ=0.05, ϕ=0.8, η2=12 m2, Ccc=10 $/unit, Cot=4 $/square unit, Cm=200 $/unit, A=1500 $, B=1000 $/unit, κ=0.7, θmax=0.9, θmin=0.1, τ=10 $/tool, Cset=200 $/unit, Chm=2 $/unit, Cftm=0.7 $/unit, Cfcm=0.2 $/unit, Cvtm=0.1 $/unit, Cvcm=0.2 $/unit, g01=5 unit, g02=7 unit, g03=8 unit, ω1=5, ω2=7, w0=8 unit, w1=5 unit, A1=10 $/unit, A2=15 $/unit, A3=20 $/unit, π01=150 $/unit, π02=140 $/unit, π03=160 $/unit, β01=0.3,β02=0.4,β03=0.5, σ1=7,σ2=6,σ3=9, L1=3 day, L2=3 day, L3=3 day, k1=5 unit, k2=7 unit, k3=8 unit, Crh=4 $/unit

    The values of the over parameters considered in this numerical case are taken from; in any case, these values considered here are practical. Two soft-computing methods, i.e., GA and PSO, are utilized to get the optimal solution to this nonlinear optimization problem. These calculations are coded in MatLab programming and run on a PC with Intel(R) Core(TM) i5-2400 3.10 GHz processor and 16.0 GB RAM in 64-bit Windows 10 operating systems. From these outcomes, the solution is illustrated in Table 2. This illustration is illuminated in arrange to find the values of si,λ,n,d,ζ1,ζ2,θ,P, and πxj along with the joint total cost JATC of the system.

    Table 2.  Optimal table.
    Cost description Cost Solution Solution
    notation by GA by PSO
    1st lost size of jth retailer s1 89.81 unit 90 unit
    s2 79.86 unit 80 unit
    s3 69.94 unit 70 unit
    Increasing rate of lot sizes λ 1.02 1.02
    number of shipments n 4 4
    Distance between two RFID readers d 9.94 feet 10 feet
    Khun tuker multipliers ζ1 0.95 2
    ζ2 0.027 1.5
    Designed reliability defined as
    θ = Number of failures/total units θ 0.06 0.002
    of used hours and θ[θmin,θmax]
    Production rate P 100.11 unit 100 unit
    Backorder price discount πx1 73.52 unit 80 unit
    for each retailer πx2 68.12 unit 90 unit
    πx3 65.00 unit 85 unit
    Total cost JATC 523374.80 521712.49

     | Show Table
    DownLoad: CSV

    Within the proposed GA, the taking after values of GA parameters have been utilized:

    Population size=500, Maximum number of generation =1000, Function tolerance =106.

    Within the proposed PSO, the taking after values of PSO parameters have been utilized:

    Population size =1000, Maximum number of generation =10, c1=1.5, c2=1.5

    PSO is comparable to the GA as these two strategies are evolutionary methods for searching for optimum values. In both methods, using some deterministic and probabilistic rules, the values of the decision variables are upgraded to another set of values of the decision variables. PSO is a comparatively recent heuristic algorithm based on the behavior of characteristics of swarming living beings; on the other hand, GA is a well-set and prevalent algorithm with numerous applications and distinctive forms. GA is a discrete optimization technique that converts the variables to binary digits 0's and 1's, so it can effectively handle discrete issues. In contrast, PSO is for continuous functions and subsequently must be altered to address the discrete problems. Unlike GA, based on the current position, the factors in PSO can take any values within the space of particles and the comparing vector of velocity. The calculation complexity cannot be handled by GA efficiently because, in GA, the number of components transforms into exceptionally large, by which the search space increases considerably. Again, GA converges to a local extremum, whereas PSO tries to get the global extremum. So, PSO is better because it requires a small number of parameters and a correspondingly less number of iterations.

    In this study, from Table 2 the minimum cost of the SC using PSO is $ 521712.49 whereas the minimum cost obtained by using GA is $ 523374.80, which is more than the previous. Thus, in this study, it is also established that PSO gives 0.32 % less cost than GA; hence, PSO is a better optimization technique than GA.

    For more practicality, some special cases due to various conditions are explained in this study. These cases compare this study with other research and establish the nobility of the study.

    Case - 1: When manufacturer applied SSSD policy

    Instead of the SSMUID policy, if the manufacturer applied the simple single-setup-single-delivery (SSSD) policy, then optimum values of the parameters and the minimum cost obtained by using GA are as follows:

    s1=60.62 (unit), s2=31.88 (unit), s3=51.42 (unit), d=9.99 (meter), ζ1=0.99, ζ2=0.50 θ=0.044, P=100.06 (unit), πx1=75.28 ($unit), πx2=66.17 ($unit), πx3=83.45 ($unit), and the Total cost JATC=525070.83.

    Also, the optimum values of the parameters and the minimum cost obtained by applying PSO are as follows:

    s1=55.27 (unit), s2=32.23 (unit), s3=68.49 (unit), d=10 (meter), ζ1=2, ζ2=1.5 θ=0.001, P=100 (unit), πx1=80 ($unit), πx2=90 ($unit), πx3=85 ($unit), and the Total cost JATC=524917.94.

    It is clear from the results of both the techniques that the SSMUID policy reduces the total cost of the SC than the SSSD policy, and hence SSMUID policy is more profitable than the SSSD policy.

    Case - 2: When manufacturer applied SSMD policy

    Instead of the SSMUID policy, if the manufacturer applied the single-setup-multi-delivery (SSMD) policy, then optimum values of the parameters and the minimum cost obtained by using GA are as follows:

    s1=89.99 (unit), s2=79.99 (unit), s3=69.99 (unit), λ = 1, n=4, d=9.99 (meter), ζ1=0.99, ζ2=0.05 θ=0.09, P=100.06 (unit), πx1=75.54 ($unit), πx2=70.42 ($unit), πx3=81.71 ($unit), and the Total cost JATC=524065.35.

    Also, the optimum values of the parameters and the minimum cost obtained by applying PSO are as follows:

    s1=90 (unit), s2=80 (unit), s3=70 (unit), λ=1, n=4, d=10 (meter), ζ1=2, ζ2=1 θ=0.002, P=100 (unit), πx1=80 ($unit), πx2=90 ($unit), πx3=85 ($unit), and the Total cost JATC=523845.67.

    It is clear from the result that the SSMUID policy reduces the total cost of the SC than the SSMD policy; hence, the SSMUID policy is more profitable than the SSMD policy. It is also noticed that the SSMD policy is more beneficial than the SSSD policy.

    Case - 3: No backorder price discount offered by the retailer

    To reduce the number of lost sales, the retailer usually offers backorder price discounts for the customers. Now consider the special case when the retailer does not provide any discounts for backorder. Then optimum values of the parameters and the minimum cost obtained by applying GA are as follows:

    s1=89.67 (unit), s2=79.52 (unit), s3=69.23 (unit), λ = 1.03, n=4, d=9.99 (meter), ζ1=0.99, ζ2=0.54 θ=0.1, P=100 (unit), and the Total cost JATC=524153.46.

    Also the optimum values of the parameters and the minimum cost obtained by applying PSO are as follows:

    s1=90 (unit), s2=80 (unit), s3=70 (unit), λ=1.02, n=4, d=10 (meter), ζ1=2, ζ2=1.5 θ=0.002, P=100 (unit), and the Total cost JATC=524065.79.

    It is clear from the result that if the retailer doesn't provide any backorder price discount for customers, it affects the SC's total cost. The total cost increases for not offering any backorder price discount, and hence backorder price discount is essential for the SC to reduce the total cost.

    An analysis of the parameters' sensitivity is explained numerically by changing that particular parameter from 50% to +50% and keeping all the remaining parameters the same for both the optimization techniques, GA and PSO. Table 3 shows the changes in both the strategies (GA and PSO). The changes are also graphically presented in Figure 6 and Figure 7 for GA and PSO, respectively.

    Table 3.  Sensitivity table.
    Para Change (%) Change in Para Change (%) Change in
    meter JTC (%) meter JTC (%)
    GA PSO GA PSO
    D1 50% 09.33 09.36 D2 50% 10.44 10.47
    25% 4.65 4.66 25% 5.21 5.22
    +25% +4.63 +4.65 +25% +5.19 +5.21
    +50% +9.25 +9.28 +50% +10.38 +10.42
    D3 50% 2.94 2.95 η1 50% +1.14 +1.15
    25% 1.39 1.39 25% +0.38 +0.38
    +25% +1.32 +1.33 +25% 0.23 0.23
    +50% +2.61 +2.62 +50% 0.38 0.38
    Crft 50% 0.57 0.57 St 50% +67.66 +67.09
    25% 0.29 0.29 25% +28.19 +27.95
    +25% +0.29 +0.29 +25% +0.00 0.01
    +50% +0.57 +0.57 +50% +0.00 0.02
    Ss 50% 16.74 16.61 Crfs1 50% 0.11 0.12
    25% 9.77 9.69 25% 0.06 0.06
    +25% +12.56 +12.45 +25% +0.06 +0.06
    +50% +27.90 +27.68 +50% +0.11 +0.12
    Crfs2 50% 11.16 11.06 l or b 50% 18.46 18.38
    25% 5.58 5.53 25% 3.59 3.60
    +25% +5.58 +5.53 +25% +14.87 +14.78
    +50% +11.16 +11.06 +50% +18.46 +18.38
    Ccc 50% 7.18 7.20 Cm 50% 18.28 18.34
    25% 3.59 3.60 25% 9.14 9.17
    +25% +3.59 +3.60 +25% +9.14 +9.17
    +50% +7.18 +7.20 +50% +18.28 +18.34
    A 50% 1.37 1.38 τ 50% 9.59 9.60
    25% 0.68 0.69 25% 4.80 4.80
    +25% +0.68 +0.69 +25% +4.80 +4.80
    +50% +1.37 +1.38 +50% +9.59 +9.60
    Cset 50% 0.02 0.02 Chm 50% 0.22 0.21
    25% 0.01 0.01 25% 0.11 0.11
    +25% +0.01 +0.01 +25% +0.11 +0.11
    +50% +0.02 +0.02 +50% +0.22 +0.21
    g11 50% 0.19 0.19 g12 50% 0.23 0.23
    25% 0.09 0.09 25% 0.12 0.12
    +25% +0.09 +0.09 +25% +0.12 +0.12
    +50% +0.19 +0.19 +50% +0.22 +0.23
    g13 50% 0.23 0.22 ω1 50% 0.61 0.61
    25% 0.12 0.12 25% 0.31 0.31
    +25% +0.12 +0.13 +25% +0.31 +0.31
    +50% +0.23 +0.22 +50% +0.61 +0.61
    ω2 50% 0.75 0.75 w1 50% 0.75 0.75
    25% 0.38 0.38 25% 0.38 0.37
    +25% +0.38 +0.38 +25% +0.38 +0.37
    +50% +0.75 +0.75 +50% +0.75 +0.75

     | Show Table
    DownLoad: CSV
    Figure 6.  Graphical representation of the sensitivity of the solution when GA is applied.
    Figure 7.  Graphical representation of the sensitivity of the solution when PSO is applied.

    From the sensitivity table (Table 3) the following conclusion may made:

    ● The total cost is affected enough due to demand. Suppose the demand for a product decreases, then the amount of production, holding, and transportation decrease parallelly. As expected in Table 3, it is clear that the total cost decreases and increases due to the decrease and increase in retailers' demand.

    ● The upside or drawback in the parameter η1, that is, the number of items in each box causes a significant change in the total cost. Moreover, if 25% and 50% expand η1, then the total cost decreases; on the other hand, if eta1 is diminished by 50% and 25%, the total cost increases. It is quite natural as the manufacturer has to buy more RFID tags to reduce the number of items in each box.

    ● The transmission and sensing radius (St and Ss) of the type 1 scanner incorporates an extraordinary effect on the total cost of the SC. Total cost increases for the diminish of transmission radius and increments of detecting radius and vice versa.

    ● The rate increment or diminish in the parameters Crfs2 (cost of Type 2 RFID scanner), l and b (length and breadth of the inspection area), Ccc (cost of CC camera), Cm (material cost), and τ (tool cost) are sensitive for the total cost. An increment within the parameters increases the total cost and diminishes within the parameters diminishes the cost.

    ● The parameters Crft (RFID tag cost), Crfs1 (cost of Type 1 RFID scanner), A (fixed manufacturing cost), Cset (setup cost of the manufacturer), Chm (holding cost of the manufacturer), g11,g12,g13 (amount of fuel consumption for returned vehicles), ω1,ω2 (carbon emission factors for fuel and electricity), w1 (variable electricity consumption) has mild impact on the total cost. The total cost increases or decreases slightly for the increment or decrease of the value of these parameters.

    ● The transmission radius of the Type 1 scanner (St) is the most sensitive parameter for the study, whereas the length and breadth (l and b) of the inspection area are the 2nd most sensitive parameter.

    ● The parameters not shown in the figure is significantly less impact on the total cost.

    The result illustrates the vital and key bits of knowledge for managers in overseeing unreliability issues and shortage issues within the SC with the joining of variable carbon emission costs, variable production, and technical up-gradation. As today's customers want quick and on-time delivery, the industry managers need to prevent the shortage problem that occurred due to unreliable players of the SC. The managers have to take suitable policies for solving the shortage problem of the SC.

    Technological up-gradation is too much essential for an SC as, without an upgrade, a company may lose its identity in the market. So the managers must take the necessary steps to upgrade the system by applying suitable technologies. This up-gradation helps for smooth conduction of the SC and also reduces the shortage problem in the SC. Also, since the transmission radius of the Type 1 RFID scanner is highly sensitive to the total cost, the managers should have to take care of this.

    The managers also have to focus on the shipment strategy the manufacturer applies as the retailer's holding cost directly depends on it. A suitable shipment strategy can diminish the "holding cost" of the retailer and helps to run the SC smoothly. Also, the managers should pay attention to environmental sustainability and have to apply strategies to save nature and reduce global warming.

    The production cost and production rate may not be fixed, so it is essential to apply a reasonable production cost depending on realistic items like material cost, time, and tool cost. Finally, the managers have to concentrate on minimizing the total cost of SC. In brief, a practical guideline is proposed in this study for the decision-makers to smooth the SC flow by reducing the shortage problem and minimizing the total cost of the SC.

    The disaster created in an SC for unreliable manufacturers and retailers is illustrated in this study. The unreliable manufacturer produced less quantity than the ordered quantity, which caused a shortage problem for the retailer. On the other hand, the unreliable retailer provided wrong information reading sales, which caused inaccurate estimation for the manufacturer. The shortage problem due to unreliable manufacturers is solved by applying a backorder price discount by the retailer. Whereas to solve the inaccurate estimation problem, the manufacturer does a technical up-gradation in the warehouse. Also, to reduce the "holding cost" of the player, the SSMUID technique is applied by the manufacturer to deliver the produced items in different shipments, which also helps to reduce the shortage problem. The variable carbon emission cost depending on fuel consumption and electricity consumption helps to improve environmental sustainability, which is beneficial for our society. Also, material and tool-dependent production costs are helping the manufacturer with the cost of production accurately. The model is solved through a realistic robust technique due to randomness in lead time demand. Finally, the total cost of the SC is optimized numerically by using two famous and popular techniques - one in GA and another in PSO. These numerical tests demonstrate the reality of the study trailed by the in-depth sensitivity analysis. {The numerical test shows that the total cost obtained by applying PSO is 0.32% less than the cost obtained using GA. It established that PSO is a more beneficial optimization method than GA.}

    To show the practicability of this model, some case studies are explained. The explained case studies show that the SSMUID technique is 0.62% beneficial compared to the SSSD policy and 0.35% compared to the SSMD policy. Offering a backorder price discount is 0.45% profitable for an SC. Lead time is one of the limitations of the study. So one can extend the study by considering lead time and proper investment for reducing the lead time [42]. Fixed ordering cost is another limitation of this study. By considering variable ordering cost, one can reduce the total system cost [16]. Consideration of stochastic demand is an interesting extension in this research field. Moreover, by enabling the role of blockchain technology in SC [51,52,53,54] and by increasing the number of the manufacturer, one can extend the current study.

    All authors declare no conflicts of interest in this study.

    An RFID tag is an upgraded tracking device utilized to identify objects by radiofrequency technology. These radio waves turn information from the tag to an RFID reader, which transmits the data to an RFID program on the computer. In this study, each box contains η1 items, then the total number of boxes is αQη1, where x is the the least integer greater than or equal to x, called ceiling function of x. Thus, the cost of each RFID tag is Crft unit, so total cost for the symmetric RFID tags is αQη1Crft unit and hence the symmetric RFID tag cost per cycle is

    DαQαQη1Crft

    RFID could be an innovation comparable in hypothesis to bar codes. An RFID scanner could be a gadget to assemble data from an RFID tag to track objects. However, the RFID tag does not need to be scanned directly, nor does it require line-of-sight to a scanner. The RFID tag must be inside the range of an RFID scanner, which ranges from 3 to 300 feet, for perfect scanning. RFID permits several things to be scanned rapidly and quickly and recognize a specific item when a few other things encompass it. In this study, to overcome the shortage issues coming from the inaccurate estimation of the manufacturer, the manufacturer will oversee the manufacturing products' total stock in the warehouse by applying RFID tags and scanners. RFID confirms the number of items stored in the warehouses. The network between the radius of sensing and the radius of transmitting is given by condition 2SsSt [55]. It isn't essential to utilize a continuously effective RFID Type 1 scanner. Moreover, that consistently low effective Type 2 scanner ought to be used, and optimization is required to optimize the ideal number of Type 1 and Type 2 scanners inside the complete range.

    If for each subdivided region, l1 the length and b1 be the breadth, then according to right-angled triangle's property (Figure 8), it takes after that St=l21+b214. For every square area St=l12 (since, l1=b1). Therefore for the area of length l and breadth b, the number of Type 1 scanner needed is l2Stb2St. Again each subdivided region of detecting radius Ss is partitioned into two zones with detecting radius rs. If d be the maximum distance between any two Type 2 scanners then rs=d2 and according to Hefeeda and Ahmadi [56], d3(μLog[131ϕ]ρ) Finally, circular area for radius of sensing Ss is πS2s and for radius of sensing rs is πd24. Subsequently, the overall number of Type 2 scanner for all Type 1 scanner is 4Ss2d2l2Stb2St. If Crfs1 is the cost of each Type 1 scanner and Crfs2 is for each Type 2 scanner, which the manufacturer pays as an speculation, the desired cost for RFID is given by

    f(d)=l2Stb2StCrfs1+4Ss2d2l2Stb2StCrfs2, (A.1)
    Figure 8.  Search area of Type 1 and Type 2 RFID scanner.

    subject to the condition d3(μLog[131ϕ]ρ) and St2Ss, where the length and the breadth of the total search area are l and b, respectively, St, Ss are the transmission radius and "sensing radius of Type 1 reader" respectively, d is the distance between two "RFID readers", ϕ is the threshold parameter (0<ϕ<1), and ρ is the decay parameter for sensing.

    Day by day, global logistics is getting faster and more complex. Modern video observation (CCTV) can offer people real-time screen security and operations assistance along the SC. At numerous events, it is essential to control other resources continually in movement, which are a part of the manufacturing process. Through CCTV, state-of-the-art video reconnaissance frameworks can track and find thousands of versatile resources simultaneously with remarkable exactness. In this way, the supervision of these resources in development, counting the work of the administrators, gets to be an easy task. This study uses downward-focused CC symmetric cameras with rectangular focus areas for video surveillance. The entire investment for symmetric CC cameras is

    lbη2Ccc

    A wireless local area network (WLAN) is a computer organization that joins two or more gadgets by employing a remote dispersion strategy. WLAN permits clients with devices to move around inside the coverage region. A remote LAN comprises numerous components, including a switch, modem, WIFI router, hub, access points, and competent wireless gadgets such as tablets, laptops, mobiles, or computers. The amount of investment needed for improving WLAN depends on the coverage area. In this study, Cwr represents the investment for improving WLAN per unit area. Hence the total investment for improving WLAN in the manufacturing house is as follows:

    lbCwr.

    Other costs like maintenance of CCTV, maintenance of WLAN, internet package etc. for technological growth per cycle is

    DαQlbCot

    Acknowledgments



    We are indebted to the ResearchGate community for helpful troubleshooting ideas during the completion of this work. We thank Ismail Shukor for setting up the GPU system and the Linux configuration and Nazirah Shukor for financing the project.

    Conflicts of interest



    The authors declare no conflict of interest.

    [1] Iguchi T, Umeda H, Kojima M, et al. (2021) Cumulative adverse event reporting of anaphylaxis after mRNA COVID-19 vaccine (Pfizer-BioNTech) injections in Japan: The first-month report. Drug Saf 44: 1209-1214. https://doi.org/10.1007/s40264-021-01104-9
    [2] Costantino M, Sellitto C, Conti V, et al. (2022) Adverse events associated with BNT162b2 and AZD1222 vaccines in the real world: Surveillance report in a single Italian vaccine center. J Clin Med 11: 1408. https://doi.org/10.3390/jcm11051408
    [3] Halstead SB (2018) Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine. Hum Vaccin Immunother 14: 2158-2162. https://doi.org/10.1080/21645515.2018.1445448
    [4] Clothier HJ, Lawrie J, Russell MA, et al. (2019) Early signal detection of adverse events following influenza vaccination using proportional reporting ratio, Victoria, Australia. PLoS One 14: e0224702. https://doi.org/10.1371/journal.pone.0224702
    [5] Masuka JT, Khoza S (2019) Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): An analysis of spontaneous reports in Vigibase® from 1997 to 2017. BMC Public Health 19: 1166. https://doi.org/10.1186/s12889-019-7482-x
    [6] Reyes MSGL, Dee EC, Ho BL (2021) Vaccination in the Philippines: experiences from history and lessons for the future. Hum Vaccin Immunother 17: 1873-1876. https://doi.org/10.1080/21645515.2020.1841541
    [7] Avolio E, Carrabba M, Kavanagh Williamson M, et al. (2021) The SARS-CoV-2 Spike protein alters human cardiac pericyte function and interaction with endothelial cells through a non-infective mechanism involving activation of CD147 receptor signalling. Eur Heart J 42: ehab724.3383. https://doi.org/10.1093/eurheartj/ehab724.3383
    [8] Avolio E, Carrabba M, Milligan R, et al. (2021) The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease. Clin Sci (Lond) 135: 2667-2689. https://doi.org/10.1042/CS20210735
    [9] Khaddaj-Mallat R, Aldib N, Bernard M, et al. (2021) SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein. Neurobiol Dis 161: 105561. https://doi.org/10.1016/j.nbd.2021.105561
    [10] Rhea EM, Logsdon AF, Hansen KM, et al. (2021) The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice. Nat Neurosci 24: 368-378. https://doi.org/10.1038/s41593-020-00771-8
    [11] Singh RD, Barry MA, Croatt AJ, et al. (2022) The spike protein of SARS-CoV-2 induces heme oxygenase-1: Pathophysiologic implications. Biochim Biophys Acta Mol Basis Dis 1868: 166322. https://doi.org/10.1016/j.bbadis.2021.166322
    [12] Ventura Fernandes BH, Feitosa NM, Barbosa AP, et al. (2022) Toxicity of spike fragments SARS-CoV-2 S protein for zebrafish: A tool to study its hazardous for human health?. Sci Total Environ 813: 152345. https://doi.org/10.1016/j.scitotenv.2021.152345
    [13] Greinacher A, Selleng K, Palankar R, et al. (2021) Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. Blood 138: 2256-2268. https://doi.org/10.1182/blood.2021013231
    [14] Greinacher A, Langer F, Makris M, et al. (2022) Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources. J Thromb Haemost 20: 149-156. https://doi.org/10.1111/jth.15572
    [15] Lavin M, Elder PT, O'Keeffe D, et al. (2021) Vaccine-induced immune thrombotic thrombocytopenia (VITT)–a novel clinico-pathological entity with heterogeneous clinical presentations. Br J Haematol 195: 76-84. https://doi.org/10.1111/bjh.17613
    [16] Leung HHL, Perdomo J, Ahmadi Z, et al. (2022) NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia. Nat Commun 13: 5206. https://doi.org/10.1038/s41467-022-32946-1
    [17] Iba T, Levy JH (2022) Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination. Trends Cardiovasc Med 32: 249-256. https://doi.org/10.1016/j.tcm.2022.02.008
    [18] Franchini M, Liumbruno GM, Pezzo M (2021) COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol 107: 173-180. https://doi.org/10.1111/ejh.13665
    [19] Jermain B, Hanafin PO, Cao Y, et al. (2020) Development of a minimal physiologically-based pharmacokinetic model to simulate lung exposure in humans following oral administration of ivermectin for COVID-19 drug repurposing. J Pharm Sci 109: 3574-3578. https://doi.org/10.1016/j.xphs.2020.08.024
    [20] Singh TU, Parida S, Lingaraju MC, et al. (2020) Drug repurposing approach to fight COVID-19. Pharmacol Rep 72: 1479-1508. https://doi.org/10.1007/s43440-020-00155-6
    [21] Dittmar M, Lee JS, Whig K, et al. (2021) Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. Cell Rep 35: 108959. https://doi.org/10.1016/j.celrep.2021.108959
    [22] Hiltzik M (2021) Column: Major study of Ivermectin, the anti-vaccine crowd's latest COVID drug, finds ‘no effect whatsoever’.Los Angeles Times. Available from: https://www.latimes.com/business/story/2021-08-11/ivermectin-no-effect-covid
    [23] Yadav R, Hasan S, Mahato S, et al. (2021) Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2. J Mol Liq 342: 116942. https://doi.org/10.1016/j.molliq.2021.116942
    [24] Moharana M, Das A, Sahu SN, et al. (2022) Evaluation of binding performance of bioactive compounds against main protease and mutant model spike receptor binding domain of SARS-CoV-2: Docking, ADMET properties and molecular dynamics simulation study. J Indian Chem Soc 99: 100417. https://doi.org/10.1016/j.jics.2022.100417
    [25] Rastmanesh R, Marotta F, Tekin I (2020) Call for mobilization of functional foods, antioxidants, and herbal antivirals in support of international campaign to control coronavirus. Bioact Comp Health Dis 3: 90-94. https://doi.org/10.31989/bchd.v3i5.717
    [26] Rolta R, Salaria D, Sharma B, et al. (2022) Methylxanthines as potential inhibitor of SARS-CoV-2: An in silico approach. Curr Pharmacol Rep 8: 149-170. https://doi.org/10.1007/s40495-021-00276-3
    [27] Batra B, Srinivasan S, Gopalakrishnan SG, et al. (2023) Molecular insights into the interaction of eighteen different variants of SARS-CoV-2 spike proteins with sixteen therapeutically important phytocompounds: in silico approach. J Biomol Struct Dyn 23: 1-28. https://doi.org/10.1080/07391102.2023.2169761
    [28] Lemkul JA, Bevan DR (2010) Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamics. J Phys Chem B 114: 1652-1660. https://doi.org/10.1021/jp9110794
    [29] Lee J, Cheng X, Swails JM, et al. (2016) CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J Chem Theory Comput 12: 405-413. https://doi.org/10.1021/acs.jctc.5b00935
    [30] Kumar Bhardwaj V, Purohit R, Kumar S (2021) Himalayan bioactive molecules as potential entry inhibitors for the human immunodeficiency virus. Food Chem 347: 128932. https://doi.org/10.1016/j.foodchem.2020.128932
    [31] Tanwar G, Mazumder AG, Bhardwaj V, et al. (2019) Target identification, screening and in vivo evaluation of pyrrolone-fused benzosuberene compounds against human epilepsy using Zebrafish model of pentylenetetrazol-induced seizures. Sci Rep 9: 7904. https://doi.org/10.1038/s41598-019-44264-6
    [32] Bhardwaj VK, Oakley A, Purohit R (2022) Mechanistic behavior and subtle key events during DNA clamp opening and closing in T4 bacteriophage. Int J Biol Macromol 208: 11-19. https://doi.org/10.1016/j.ijbiomac.2022.03.021
    [33] Bhardwaj V, Purohit R (2020) Computational investigation on effect of mutations in PCNA resulting in structural perturbations and inhibition of mismatch repair pathway. J Biomol Struct Dyn 38: 1963-1974. https://doi.org/10.1080/07391102.2019.1621210
    [34] Purohit R, Rajasekaran R, Sudandiradoss C, et al. (2008) Studies on flexibility and binding affinity of Asp25 of HIV-1 protease mutants. Int J Biol Macromol 42: 386-391. https://doi.org/10.1016/j.ijbiomac.2008.01.011
    [35] Kumar A, Rajendran V, Sethumadhavan R, et al. (2012) In silico prediction of a disease-associated STIL mutant and its affect on the recruitment of centromere protein J (CENPJ). FEBS Open Bio 2: 285-293. https://doi.org/10.1016/j.fob.2012.09.003
    [36] Narayanan N, Nair DT (2020) Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the SARS-CoV-2 virus. IUBMB Life 72: 2112-2120. https://doi.org/10.1002/iub.2359
    [37] Zhang H, Yang Y, Li J, et al. (2020) A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro. PLoS Comput Biol 16: e1008489. https://doi.org/10.1371/journal.pcbi.1008489
    [38] Shree P, Mishra P, Selvaraj C, et al. (2022) Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants–Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi)—a molecular docking study. J Biomol Struct Dyn 40: 190-203. https://doi.org/10.1080/07391102.2020.1810778
    [39] Chen C, Zhang XR, Ju ZY, et al. (2020) Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies. Zhonghua Shao Shang Za Zhi 36: 471-475. https://doi.org/10.3760/cma.j.cn501120-20200224-00088
    [40] Elfiky AA (2020) Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci 253: 117592. https://doi.org/10.1016/j.lfs.2020.117592
    [41] Dai W, Zhang B, Jiang XM, et al. (2020) Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 368: 1331-1335. https://doi.org/10.1126/science.abb4489
    [42] Dhankhar P, Dalal V, Singh V, et al. (2020) Computational guided identification of novel potent inhibitors of N-terminal domain of nucleocapsid protein of severe acute respiratory syndrome coronavirus 2. J Biomol Struct Dyn 40: 4084-4099. https://doi.org/10.1080/07391102.2020.1852968
    [43] Lan J, Ge J, Yu J (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581: 215-220. https://doi.org/10.1038/s41586-020-2180-5
    [44] Kadioglu O, Saeed M, Greten HJ, et al. (2021) Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning. Comput Biol Med 133: 104359. https://doi.org/10.1016/j.compbiomed.2021.104359
    [45] Mishra A, Rathore AS (2022) RNA dependent RNA polymerase (RdRp) as a drug target for SARS-CoV2. J Biomol Struct Dyn 40: 6039-6051. https://doi.org/10.1080/07391102.2021.1875886
    [46] Lee L Dengue death toll rises in Malaysia, number of cases close to double (2019). Available from: https://www.insider.com/dengue-death-toll-rises-in-malaysia-number-of-cases-close-to-double-2019-8
    [47] Sharma N, Mishra KP, Chanda S, et al. (2019) Evaluation of anti-dengue activity of Carica papaya aqueous leaf extract and its role in platelet augmentation. Arch Virol 164: 1095-1110. https://doi.org/10.1007/s00705-019-04179-z
    [48] Hettige S (2008) Salutary effects of Carica papaya leaf extract in dengue fever patients—a pilot study. Sri Lankan Family Physician 29: 17-19.
    [49] Hettige S (2017) The use of dried carica papaya leaf capsules in dengue fever patients in the recent dengue epidemic in June–August 2017. Sri Lankan Family Phys 33: 21-26.
    [50] Assir MZK, Mansoor H, Waseem T, et al. (2012) Effect of papaya leaf extract on platelet count in dengue fever: a randomized controlled trial (PLEAD Trial). Int J Infect Dis 16: E473. https://doi.org/10.1016/j.ijid.2012.05.686
    [51] Yunita F, Hanani E, Kristianto J (2012) The effect of Carica papaya L. leaves extract capsules on platelets count and hematocrit level in dengue fever patient. Int J Med Aromat Plants 2: 573-578.
    [52] Subenthiran S, Choon TC, Cheong KC, et al. (2013) Carica papaya leaves juice significantly accelerates the rate of increase in platelet count among patients with dengue fever and dengue haemorrhagic fever. Evid-Based Compl Alt Med 2013: 616737. https://doi.org/10.1155/2013/616737
    [53] Singhai A, Juneja V, Abbas S, et al. (2016) The effect of Carica papaya leaves extract capsules on platelets count and hematocrit levelsin acute febrile illness with thrombocytopenia patient. Int J Med Res Health Sci 5: 254-257.
    [54] Adarsh VB, Doddamane K, Kumar VD (2017) Role of carica papaya leaf product in improving the platelet count in patients with dengue fever. Int J Res Medi 6: 63-68.
    [55] Semwal DK, Dahiya RS, Joshi N, et al. (2018) Preclinical and clinical studies to evaluate the effect of carica papaya leaf extract on platelets. Curr Tradit Med 4: 297-304. https://doi.org/10.2174/2215083805666190124162640
    [56] Shetty D, Manoj A, Jain D, et al. (2019) The effectiveness of carica papaya leaf extract in children with dengue fever. ejbps 6: 380-383.
    [57] Srikanth BK, Reddy L, Biradar S, et al. (2019) An open-label, randomized prospective study to evaluate the efficacy and safety of Carica papaya leaf extract for thrombocytopenia associated with dengue fever in pediatric subjects. Pediatric Health Med Ther 10: 5-11. https://doi.org/10.2147/PHMT.S176712
    [58] Janagan T, Sridevi SA (2020) Pharmacoepidemiological study of the usage of caripill for the dengue patients in an urban health setup among the registered medical practitioners. IP Int J Compr Adv Pharmacol 5: 42-44. http://doi.org/10.18231/j.ijcaap.2020.010
    [59] Sathyapalan DT, Padmanabhan A, Moni M, et al. (2020) Efficacy & safety of carica papaya leaf extract (CPLE) in severe thrombocytopenia (≤ 30,000/µL) in adult dengue—Results of a pilot study. PLoS One 15: e0228699. https://doi.org/10.1371/journal.pone.0228699
    [60] Solanki SG, Trivedi P (2020) Evaluation of the efficacy of Carica papaya leaf extract on platelet counts in dengue patients. J Adv Sci Res 11: 62-65.
    [61] Karimi A, Majlesi M, Rafieian-Kopaei M (2015) Herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol 4: 27-30.
    [62] Malavige GN, Jeewandara C, Ogg GS (2022) Dengue and COVID-19: Two sides of the same coin. J Biomed Sci 29: 48. https://doi.org/10.1186/s12929-022-00833-y
    [63] Favaloro EJ, Pasalic L, Lippi G (2022) Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT). Clin Chem Lab Med (CCLM) 60: 7-17. https://doi.org/10.1515/cclm-2021-1039
    [64] Mo P, Xing Y, Xiao Y, et al. (2020) Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 73: e4208-e4213. https://doi.org/10.1093/cid/ciaa270
    [65] Jiang SQ, Huang QF, Xie WM, et al. (2020) The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants. Br J Haematol 190: e29-e33. https://doi.org/10.1111/bjh.16817
    [66] Larsen JB, Pasalic L, Hvas AM (2020) Platelets in Coronavirus disease 2019. Semin Thromb Hemost 46: 823-825. https://doi.org/10.1055/s-0040-1710006
    [67] Chuansumrit A, Chaiyaratana W (2014) Hemostatic derangement in dengue hemorrhagic fever. Thromb Res 133: 10-16. https://doi.org/10.1016/j.thromres.2013.09.028
    [68] Feldmann M, Maini RN, Woody JN, et al. (2020) Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet 395: 1407-1409. https://doi.org/10.1016/S0140-6736(20)30858-8
    [69] Robinson PC, Richards D, Tanner HL, et al. (2020) Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment. Lancet Rheumatol 2: e653-e655. https://doi.org/10.1016/S2665-9913(20)30309-X
    [70] Norahmad NA, Mohd Abd Razak MR, Mohmad Misnan N, et al. (2019) Effect of freeze-dried Carica papaya leaf juice on inflammatory cytokines production during dengue virus infection in AG129 mice. BMC Complement Altern Med 19: 49. https://doi.org/10.1186/s12906-019-2438-3
    [71] Binachon C Inhibiteur de TNF-alpha. FR2973705A1 (2012).
    [72] Tisoncik JR, Korth MJ, Simmons CP, et al. (2012) Into the Eye of the Cytokine Storm. Microbiol Mol Biol Rev 76: 16-32. https://doi.org/10.1128/MMBR.05015-11
    [73] Adarsh M, Abraham A, Kavitha P, et al. (2021) Severe thrombocytopenia in COVID-19: A conundrum in dengue-endemic areas. Indian J Crit Care Med 25: 465-466. https://doi.org/10.5005/jp-journals-10071-23778
    [74] Zunjar V, Dash RP, Jivrajani M, et al. (2016) Antithrombocytopenic activity of carpaine and alkaloidal extract of Carica papaya Linn. leaves in busulfan induced thrombocytopenic Wistar rats. J Ethnopharmacol 181: 20-25. https://doi.org/10.1016/j.jep.2016.01.035
    [75] Munir S, Liu ZW, Tariq T, et al. (2022) Delving into the therapeutic potential of Carica papaya leaf against thrombocytopenia. Molecules 27: 2760. https://doi.org/10.3390/molecules27092760
    [76] Shukor MS, Shukor MY Potential herbal-based treatment for COVID-19, a case for papaya leaves extract (2020). Available from: https://vixra.org/pdf/2004.0087v8.pdf
    [77] Saif R, Zafar MO, Raza MH, et al. (2020) Computational prediction of Carica papaya extracts as potential drug agents against RNA polymerase and Spike proteins of SARS-nCoV2. Res Square 1–11. https://doi.org/10.21203/rs.3.rs-105301/v1
    [78] Chen YC (2015) Beware of docking!. Trends Pharmacol Sci 36: 78-95. https://doi.org/10.1016/j.tips.2014.12.001
    [79] Yesudhas D, Srivastava A, Sekijima M, et al. (2021) Tackling Covid-19 using disordered-to-order transition of residues in the spike protein upon angiotensin-converting enzyme 2 binding. Proteins 89: 1158-1166. https://doi.org/10.1002/prot.26088
    [80] Zhang L, Lin D, Sun X, et al. (2020) Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science 368: 409-412. https://doi.org/10.1126/science.abb3405
    [81] Hu X, Zhou Z, Li F, et al. (2021) The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing. Heliyon 7: e06387. https://doi.org/10.1016/j.heliyon.2021.e06387
    [82] Suravajhala R, Parashar A, Choudhir G, et al. (2021) Molecular docking and dynamics studies of curcumin with COVID-19 proteins. Netw Model Anal Health Inform Bioinforma 10: 44. https://doi.org/10.1007/s13721-021-00312-8
    [83] Frisch MJ, Trucks GW, Schlegel HB, et al. (2016) Gaussiañ16 Revision C.01. Gaussian, Inc, Wallingford CT .
    [84] Morris GM, Huey R, Lindstrom W, et al. (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791. https://doi.org/10.1002/jcc.21256
    [85] Mehta J, Utkarsh K, Fuloria S, et al. (2022) Antibacterial potential of bacopa monnieri (L.) Wettst. and its bioactive molecules against uropathogens—An in silico study to identify potential lead molecule(s) for the development of new drugs to treat urinary tract infections. Molecules 27: 4971. https://doi.org/10.3390/molecules27154971
    [86] Baghban R, Farajnia S, Ghasemi Y, et al. (2021) Engineering of ocriplasmin variants by bioinformatics methods for the reduction of proteolytic and autolytic activities. Iran J Med Sci 46: 454-467. https://doi.org/10.30476/ijms.2020.86984.1705
    [87] Pereira RCC, Lourenço AL, Terra L, et al. (2017) Marine diterpenes: Molecular modeling of thrombin inhibitors with potential biotechnological application as an antithrombotic. Mar Drugs 15: 79. https://doi.org/10.3390/md15030079
    [88] Gapsys V, Michielssens S, Seeliger D, et al. (2015) pmx: Automated protein structure and topology generation for alchemical perturbations. J Comput Chem 36: 348-354. https://doi.org/10.1002/jcc.23804
    [89] Chakraborty B, Sengupta C, Pal U, et al. (2017) Acridone in biological nanocavity: A detailed spectroscopic and docking analyses of probing both the tryptophan residues of bovine serum albumin. New J Chem 41: 12520-12534. https://doi.org/10.1039/C7NJ02454A
    [90] Kumari R, Kumar R, Lynn A (2014) g_mmpbsa—A GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54: 1951-1962. https://doi.org/10.1021/ci500020m
    [91] Kang S, Yang M, Hong Z, et al. (2020) Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm Sin B 10: 1228-1238. https://doi.org/10.1016/j.apsb.2020.04.009
    [92] Kabinger F, Stiller C, Schmitzová J, et al. (2021) Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol 28: 740-746. https://doi.org/10.1038/s41594-021-00651-0
    [93] Redhead MA, Owen CD, Brewitz L, et al. (2021) Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19. Sci Rep 11: 13208. https://doi.org/10.1038/s41598-021-92416-4
    [94] Han P, Li L, Liu S, et al. (2022) Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell 185: 630-640. https://doi.org/10.1016/j.cell.2022.01.001
    [95] He MM, Smith AS, Oslob JD, et al. (2005) Small-molecule inhibition of TNF-alpha. Science 310: 1022-1025. https://doi.org/10.1126/science.1116304
    [96] Yamada T, Kurihara K, Ohnishi Y, et al. (2013) Neutron and X-ray crystallographic analysis of the human α-thrombin-bivalirudin complex at pD 5.0: Protonation states and hydration structure of the enzyme-product complex. BBA–Proteins Proteom 1834: 1532-1538. https://doi.org/10.1016/j.bbapap.2013.05.014
    [97] Doak BC, Over B, Giordanetto F, et al. (2014) Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates. Chem Biol 21: 1115-1142. https://doi.org/10.1016/j.chembiol.2014.08.013
    [98] Machado D, Girardini M, Viveiros M, et al. (2018) Challenging the drug-likeness dogma for new drug discovery in tuberculosis. Front Microbiol 9: 1367. https://doi.org/10.3389/fmicb.2018.01367
    [99] Khan A, Tahir Khan M, Saleem S, et al. (2020) Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein. Comput Struct Biotechnol J 18: 2174-2184. https://doi.org/10.1016/j.csbj.2020.08.006
    [100] Ray M, Sarkar S, Rath SN (2020) Druggability for COVID-19: In silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2. Genomics Inform 18: e43. https://doi.org/10.5808/GI.2020.18.4.e43
    [101] Eweas AF, Alhossary AA, Abdel-Moneim AS (2021) Molecular docking reveals ivermectin and remdesivir as potential repurposed drugs against SARS-CoV-2. Front Microbiol 11: 592908. https://doi.org/10.3389/fmicb.2020.592908
    [102] Falana M, Nurudeen Q (2020) Analysis of secondary metabolites and in vitro evaluation of extracts of Carica papaya and Azadirachta indica leaves on selected human pathogens. Notulae Scientia Biologicae 12: 57-73. https://doi.org/10.15835/nsb12110541
    [103] Razak MRMA, Misnan NM, Jelas NHM, et al. (2018) The effect of freeze-dried Carica papaya leaf juice treatment on NS1 and viremia levels in dengue fever mice model. BMC Complement Altern Med 18: 320. https://doi.org/10.1186/s12906-018-2390-7
    [104] Omar HR, Komarova I, El-Ghonemi M, et al. (2012) Licorice abuse: time to send a warning message. Ther Adv Endocrinol Metab 3: 125-138.
    [105] Rahayu SE, Leksono AS, Gama ZP, et al. (2020) The active compounds composition and antifeedant activity of leaf extract of two cultivar Carica papaya L. on Spodoptera litura F, Larvae. AIP Conf Proc 2231. https://doi.org/10.1063/5.0002677
    [106] Canini A, Alesiani D, D'Arcangelo G, et al. (2007) Gas chromatography–mass spectrometry analysis of phenolic compounds from Carica papaya L. leaf. J Food Compos Anal 20: 584-590. https://doi.org/10.1016/j.jfca.2007.03.009
    [107] Radhakrishnan N, Lam KW, Norhaizan ME (2017) Molecular docking analysis of Carica papaya Linn constituents as antiviral agent. Int Food Res J 24: 1819-1825.
    [108] Martin RJ, Robertson AP, Choudhary S (2021) Ivermectin: An Anthelmintic, an Insecticide, and Much More. Trends Parasitol 37: 48-64. https://doi.org/10.1016/j.pt.2020.10.005
    [109] Adegbola PI, Semire B, Fadahunsi OS, et al. (2021) Molecular docking and ADMET studies of Allium cepa, Azadirachta indica and Xylopia aethiopica isolates as potential anti-viral drugs for Covid-19. VirusDis 32: 85-97. https://doi.org/10.1007/s13337-021-00682-7
    [110] Nagar PR, Gajjar ND, Dhameliya TM (2021) In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysis. J Mol Struct 1246: 131190. https://doi.org/10.1016/j.molstruc.2021.131190
    [111] Ayipo YO, Ahmad I, Najib YS, et al. (2022) Molecular modelling and structure-activity relationship of a natural derivative of o-hydroxybenzoate as a potent inhibitor of dual NSP3 and NSP12 of SARS-CoV-2: In silico study. J Biomol Struct Dyn 41: 1959-1977. https://doi.org/10.1080/07391102.2022.2026818
    [112] Elkarhat Z, Charoute H, Elkhattabi L, et al. (2022) Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses. J Biomol Struct Dyn 40: 361-374. https://doi.org/10.1080/07391102.2020.1813628
    [113] de Leon VN, Manzano JAH, Pilapil DYH, et al. Repurposing multi-targeting plant natural product scaffolds in silico against SARS-CoV-2 non-structural proteins implicated in viral pathogenesis (2021). https://doi.org/10.26434/chemrxiv.14125433.v1
    [114] Wang B, Svetlov V, Wolf YI, et al. (2021) Allosteric activation of SARS-CoV-2 RNA-dependent RNA polymerase by remdesivir triphosphate and other phosphorylated nucleotides. mBio 12: e0142321. https://doi.org/10.1101/2021.01.24.428004
    [115] Peng L, Tian X, Shen L, et al. (2020) Identifying effective antiviral drugs against SARS-CoV-2 by drug repositioning through virus-drug association prediction. Front Genet 11: 577387. https://doi.org/10.3389/fgene.2020.577387
    [116] Balkrishna A, Mittal R, Arya V (2021) Computational evidences of phytochemical mediated disruption of pLpro driven replication of SARS-CoV-2: A therapeutic approach against COVID-19. Curr Pharm Biotechnol 22: 1350-1359. https://doi.org/10.2174/1389201021999201110204116
    [117] Nugroho A, Heryani H, Choi JS (2017) Identification and quantification of flavonoids in Carica papaya leaf and peroxynitrite-scavenging activity. Asian Pac J Trop Bio 7: 208-213. https://doi.org/10.1016/j.apjtb.2016.12.009
    [118] Kresge N, Simoni RD, Hill RL (2005) Hemorrhagic Sweet Clover Disease, Dicumarol, and Warfarin: The Work of Karl Paul Link. J Biol Chem 280: e6-e7. https://doi.org/10.1016/S0021-9258(19)62862-0
    [119] Caly L, Druce JD, Catton MG, et al. (2020) The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir Res 178: 104787. https://doi.org/10.1016/j.antiviral.2020.104787
    [120] Elekofehinti OO, Iwaloye O, Famusiwa CD, et al. (2021) Identification of main protease of coronavirus SARS-CoV-2 (Mpro) inhibitors from Melissa officinalis. Curr Drug Discov Technol 18: e17092020186048. https://doi.org/10.2174/1570163817999200918103705
    [121] Mahmoud A, Mostafa A, Al-Karmalawy AA, et al. (2021) Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies. Heliyon 7: e07962. https://doi.org/10.1016/j.heliyon.2021.e07962
    [122] Bzówka M, Mitusińska K, Raczyńska A, et al. (2020) Structural and evolutionary analysis indicate that the SARS-CoV-2 Mpro is a challenging target for small-molecule inhibitor design. Int J Mol Sci 21: 3099. https://doi.org/10.3390/ijms21093099
    [123] Jin Z, Du X, Xu Y, et al. (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582: 289-293. https://doi.org/10.1038/s41586-020-2223-y
    [124] Owen DR, Allerton CMN, Anderson AS, et al. (2021) An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science 374: 1586-1593.
    [125] Yu W, Wu X, Zhao Y, et al. (2021) Computational simulation of HIV protease inhibitors to the main protease (Mpro) of SARS-CoV-2: Implications for COVID-19 drugs design. Molecules 26: 7385. https://doi.org/10.3390/molecules26237385
    [126] Khor B -K., Chear NJ -Y., Azizi J, et al. (2021) Chemical composition, antioxidant and cytoprotective potentials of Carica papaya leaf extracts: A comparison of supercritical fluid and conventional extraction methods. Molecules 26: 1489. https://doi.org/10.3390/molecules26051489
    [127] Anjum V, Arora P, Ansari SH, et al. (2017) Antithrombocytopenic and immunomodulatory potential of metabolically characterized aqueous extract of Carica papaya leaves. Pharm Biol 55: 2043-2056. https://doi.org/10.1080/13880209.2017.1346690
    [128] Wrapp D, Wang N, Corbett KS, et al. (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367: 1260-1263. https://doi.org/10.1126/science.abb2507
    [129] Candelli M, Rossi E, Valletta F, et al. (2021) Immune thrombocytopenic purpura after SARS-CoV-2 vaccine. Br J Haematol 194: 547-549. https://doi.org/10.1111/bjh.17508
    [130] Kircheis R (2021) Coagulopathies after vaccination against SARS-CoV-2 may be derived from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-triggered signaling pathways. Int J Mol Sci 22: 10791. https://doi.org/10.3390/ijms221910791
    [131] Theoharides TC, Conti P (2021) Be aware of SARS-CoV-2 spike protein: There is more than meets the eye. J Biol Regul Homeost Agents 35: 833-838. https://doi.org/10.23812/THEO_EDIT_3_21
    [132] Wise J (2021) Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ 372: n699. https://doi.org/10.1136/bmj.n699
    [133] Banks WA, Erickson MA (2022) The next chapter for COVID-19: A respiratory virus inflames the brain. Brain Behav Immun 101: 286-287. https://doi.org/10.1016/j.bbi.2022.01.017
    [134] Caohuy H, Eidelman O, Chen T, et al. Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 Spike protein (2022)2022:. https://doi.org/10.1101/2022.01.18.476803
    [135] Nugent MA (2022) The future of the COVID-19 pandemic: How good (or bad) can the SARS-CoV2 Spike protein get?. Cells 11: 855. https://doi.org/10.3390/cells11050855
    [136] Theoharides TC (2022) Could SARS-CoV-2 Spike protein be responsible for long-COVID syndrome?. Mol Neurobiol 59: 1850-1861. https://doi.org/10.1007/s12035-021-02696-0
    [137] Sakkiah S, Guo W, Pan B (2021) Elucidating interactions between SARS-CoV-2 trimeric Spike protein and ACE2 using homology modeling and molecular dynamics simulations. Front Chem 8: 622632. https://doi.org/10.3389/fchem.2020.622632
    [138] Entzminger KC, Fleming JK, Entzminger PD, et al. (2023) Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including BQ.1.1, CA.3.1, CH.1.1, XBB.1.16, and XBB.1.5. Antib Ther 6: 108-118. https://doi.org/10.1093/abt/tbad006
    [139] Wu L, Zhou L, Mo M, et al. (2022) SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2. Sig Transduct Target Ther 7: 8. https://doi.org/10.1038/s41392-021-00863-2
    [140] Bennett RN, Kiddle G, Wallsgrove RM (1997) Biosynthesis of benzylglucosinolate, cyanogenic glucosides and phenylpropanoids in Carica papaya. Phytochemistry 45: 59-66. https://doi.org/10.1016/S0031-9422(96)00787-X
    [141] He MM, Smith AS, Oslob JD, et al. (2005) Small-molecule inhibition of TNF-α. Science 310: 1022-1025. https://doi.org/10.1126/science.1116304
    [142] Zia K, Ashraf S, Jabeen A, et al. (2020) Identification of potential TNF-α inhibitors: from in silico to in vitro studies. Sci Rep 10: 20974. https://doi.org/10.1038/s41598-020-77750-3
    [143] Yoshikawa M, Toyohara M, Ueda S, et al. (1999) Glycyrrhizin inhibits TNF-induced, but not Fas-mediated, apoptosis in the human hepatoblastoma line HepG2. Biol Pharm Bull 22: 951-955. https://doi.org/10.1248/bpb.22.951
    [144] Wang YM, Du GQ (2016) Glycyrrhizic acid prevents enteritis through reduction of NF‑κB p65 and p38MAPK expression in rat. Mol Med Rep 13: 3639-3646. https://doi.org/10.3892/mmr.2016.4981
    [145] Boyenle ID, Adelusi TI, Ogunlana AT, et al. (2022) Consensus scoring-based virtual screening and molecular dynamics simulation of some TNF-alpha inhibitors. Inform Med Unlocked 28: 100833. https://doi.org/10.1016/j.imu.2021.100833
    [146] Becher Y, Goldman L, Schacham N, et al. (2020) D-dimer and C-reactive protein blood levels over time used to predict pulmonary embolism in two COVID-19 patients. Eur J Case Rep Intern Med 7: 001725. https://doi.org/10.12890/2020_001725
    [147] Chi Y, Ge Y, Wu B, et al. (2020) Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China. J Infect Dis 222: 746-754. https://doi.org/10.1093/infdis/jiaa363
    [148] Porfidia A, Pola R (2020) Venous thromboembolism in COVID-19 patients. J Thromb Haemost 18: 1516-1517. https://doi.org/10.1111/jth.14842
    [149] Porres-Aguilar M, Torres-Machorro A, Aurón M (2020) Trombólisis en niños con tromboembolia pulmonar asociada a COVID-19. Gac Med Mex 156: 618-618.
    [150] Schulman S, Hu Y, Konstantinides S (2020) Venous thromboembolism in COVID-19. Thromb Haemost 120: 1642-1653. https://doi.org/10.1055/s-0040-1718532
    [151] Tang N, Li D, Wang X, et al. (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18: 844-847. https://doi.org/10.1111/jth.14768
    [152] Aydın FY, Demircan V (2021) Diagnosis and management of coronavirus disease-associated immune thrombocytopenia: a case series. Rev Soc Bras Med Trop 54: e0029. https://doi.org/10.1590/0037-8682-0029-2021
    [153] Pranata R, Lim MA, Yonas E, et al. (2021) Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis. Epidemiol Infect 149: e40. https://doi.org/10.1017/S0950268821000236
    [154] Perreau M, Suffiotti M, Marques-Vidal P, et al. (2021) The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients. Nat Commun 12: 4888. https://doi.org/10.1038/s41467-021-25191-5
    [155] Parves MR, Mahmud S, Riza YM, et al. (2020) Inhibition of TNF-alpha using plant-derived small molecules for treatment of inflammation-mediated diseases. Proceedings 79: 13. https://doi.org/10.3390/IECBM2020-08586
    [156] Paidi RK, Jana M, Raha S, et al. (2021) Eugenol, a component of Holy Basil (Tulsi) and common spice clove, inhibits the interaction between SARS-CoV-2 Spike S1 and ACE2 to induce therapeutic responses. J Neuroimmune Pharmacol 16: 743-755. https://doi.org/10.1007/s11481-021-10028-1
    [157] Junqueira C, Crespo Â, Ranjbar S, et al. (2022) FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606: 576-584. https://doi.org/10.1038/s41586-022-04702-4
    [158] Bode W, Turk D, Karshikov A (1992) The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci 1: 426-471. https://doi.org/10.1002/pro.5560010402
    [159] Hartley BS (1970) Homologies in serine proteinases. Phil Trans R Soc Lond B 257: 77-87. https://doi.org/10.1098/rstb.1970.0010
    [160] Mauricio I, Francischetti B, Monteiro RQ, et al. (1997) Identification of glycyrrhizin as a thrombin inhibitor. Biochem Biophys Res Commun 235: 259-263. https://doi.org/10.1006/bbrc.1997.6735
    [161] Mendes-Silva W, Assafim M, Ruta B, et al. (2003) Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor. Thromb Res 112: 93-98. https://doi.org/10.1016/j.thromres.2003.10.014
    [162] Zhou P, Huang JL (2020) Prediction of material foundation of Ling-Gui-Zhu-Gan decoction for chronic heart failure based on molecular docking. Pak J Pharm Sci 33: 1459-1464.
    [163] Yu X, Wei LH, Zhang JK, et al. (2019) Anthraquinones from Cassiae semen as thrombin inhibitors: in vitro and in silico studies. Phytochemistry 165: 112025. https://doi.org/10.1016/j.phytochem.2019.04.018
    [164] Alam W (2021) COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management. Sci Prog 104: 368504211025927. https://doi.org/10.1177/00368504211025927
    [165] Ganzel C, Ben-Chetrit E (2021) Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. Isr Med Assoc J 23: 341.
    [166] Garnier M, Curado A, Billoir P, et al. (2021) Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia. Diagn Interv Imaging 102: 649-650. https://doi.org/10.1016/j.diii.2021.04.005
    [167] Gupta A, Sardar P, Cash ME, et al. (2021) Covid-19 vaccine—induced thrombosis and thrombocytopenia-a commentary on an important and practical clinical dilemma. Prog Cardiovasc Dis 67: 105-107. https://doi.org/10.1016/j.pcad.2021.05.001
    [168] Malik B, Kalantary A, Rikabi K, et al. (2021) Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Rep 14: e243975. https://doi.org/10.1136/bcr-2021-243975
    [169] Novak N, Tordesillas L, Cabanillas B (2021) Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int Rev Immunol 41: 438-447. https://doi.org/10.1080/08830185.2021.1939696
    [170] Porres-Aguilar M, Lazo-Langner A, Panduro A, et al. (2021) COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis. Ann Hepatol 23: 100356. https://doi.org/10.1016/j.aohep.2021.100356
    [171] Scharf RE, Alberio L (2021) COVID-19: SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. Hamostaseologie 41: 179-182. https://doi.org/10.1055/a-1369-3488
    [172] Toom S, Wolf B, Avula A, et al. (2021) Familial thrombocytopenia flare-up following the first dose of mRNA-1273 Covid-19 vaccine. Am J Hematol 96: E134-E135. https://doi.org/10.1002/ajh.26128
    [173] Welsh KJ, Baumblatt J, Chege W, et al. (2021) Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 39: 3329-3332. https://doi.org/10.1016/j.vaccine.2021.04.054
    [174] Chaves OA, Sacramento CQ, Fintelman-Rodrigues N, et al. (2021) Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication by targeting its major protease in a non-competitive way. J Mol Cell Biol 14: mjac039. https://doi.org/10.1093/jmcb/mjac039
    [175] Morishima Y, Shibutani T, Noguchi K, et al. (2021) Edoxaban, a direct oral factor Xa inhibitor, ameliorates coagulation, microvascular thrombus formation, and acute liver injury in a lipopolysaccharide-induced coagulopathy model in rats. J Thromb Thrombolysis 52: 9-17. https://doi.org/10.1007/s11239-021-02381-y
    [176] Cavasotto CN (2020) Binding free energy calculation using quantum mechanics aimed for drug lead optimization. Methods Mol Biol 2114: 257-268. https://doi.org/10.1007/978-1-0716-0282-9_16
    [177] El-Demerdash A, Al-Karmalawy AA, Abdel-Aziz TM, et al. (2021) Investigating the structure–activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors. RSC Adv 11: 31339-31363. https://doi.org/10.1039/d1ra05817g
    [178] Cruz JN, Silva SG, Pereira DS, et al. (2022) In silico evaluation of the antimicrobial activity of thymol—major compounds in the essential oil of Lippia thymoides Mart. & Schauer (Verbenaceae). Molecules 27: 4768. https://doi.org/10.3390/molecules27154768
    [179] Kroemer RT, Vulpetti A, McDonald JJ, et al. (2004) Assessment of docking poses:  Interactions-Based Accuracy Classification (IBAC) versus crystal structure deviations. J Chem Inf Comput Sci 44: 871-881. https://doi.org/10.1021/ci049970m
    [180] Cole JC, Murray CW, Nissink JWM, et al. (2005) Comparing protein-ligand docking programs is difficult. Proteins 60: 325-332. https://doi.org/10.1002/prot.20497
    [181] Rueda M, Abagyan R (2016) Best practices in docking and activity prediction. bioRxiv : 039446. https://doi.org/10.1101/039446
    [182] Abo Elmaaty A, Alnajjar R, Hamed MIA, et al. (2021) Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: Theoretical study. RSC Adv 11: 10027-10042. https://doi.org/10.1039/d0ra10674g
    [183] Al-Karmalawy A, Alnajjar R, Dahab MM, et al. (2021) Molecular docking and dynamics simulations reveal the potential of anti-HCV drugs to inhibit COVID-19 main protease. Pharm Sci 27: S109-S121. https://doi.org/10.34172/PS.2021.3
    [184] Alnajjar R, Mohamed N, Kawafi N (2021) Bicyclo[1.1.1]Pentane as phenyl substituent in atorvastatin drug to improve physicochemical properties: Drug-likeness, DFT, pharmacokinetics, docking, and molecular dynamic simulation. J Mol Struct 1230: 129628. https://doi.org/10.1016/j.molstruc.2020.129628
    [185] Han D, Wang H, Wujieti B, et al. (2021) Insight into the drug resistance mechanisms of GS-9669 caused by mutations of HCV NS5B polymerase via molecular simulation. Comput Struct Biotechnol J 19: 2761-2774. https://doi.org/10.1016/j.csbj.2021.04.026
    [186] Isley WC, Urick AK, Pomerantz WCK, et al. (2016) Prediction of (19)F NMR chemical shifts in labeled proteins: Computational protocol and case study. Mol Pharm 13: 2376-2386. https://doi.org/10.1021/acs.molpharmaceut.6b00137
    [187] Rolta R, Yadav R, Salaria D, et al. (2020) In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: An approach to prevent virus assembly. J Biomol Struct Dyn 39: 7017-7034. https://doi.org/10.1080/07391102.2020.1804457
    [188] Amin M, Abbas G (2021) Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein—an in silico insight into the comparative efficacy of repurposing antiviral drugs. J Biomol Struct Dyn 39: 4243-4255. https://doi.org/10.1080/07391102.2020.1775703
    [189] Fayyazi N, Mostashari-Rad T, Ghasemi JB, et al. (2021) Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19. J Biomol Struct Dyn 40: 11787-11808. https://doi.org/10.1080/07391102.2021.1965914
    [190] Tatar G, Ozyurt E, Turhan K (2021) Computational drug repurposing study of the RNA binding domain of SARS-CoV-2 nucleocapsid protein with antiviral agents. Biotechnol Prog 37: e3110. https://doi.org/10.1002/btpr.3110
    [191] Yadav R, Imran M, Dhamija P, et al. (2021) Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2. J Biomol Struct Dyn 39: 4433-4448. https://doi.org/10.1080/07391102.2020.1778536
    [192] Shirvanyants D, Ramachandran S, Mei Y, et al. (2014) Pore dynamics and conductance of RyR1 transmembrane domain. Biophys J 106: 2375-2384. https://doi.org/10.1016/j.bpj.2014.04.023
    [193] Gesto D, Cerqueira NMFSA, Ramos MJ, et al. (2014) Discovery of new druggable sites in the anti-cholesterol target HMG-CoA reductase by computational alanine scanning mutagenesis. J Mol Model 20: 2178. https://doi.org/10.1007/s00894-014-2178-8
    [194] Zhu L, Gong Y, Lju H, et al. (2021) Mechanisms of melatonin binding and destabilizing the protofilament and filament of tau R3–R4 domains revealed by molecular dynamics simulation. Phys Chem Chem Phys 23: 20615-20626. https://doi.org/10.1039/d1cp03142b
    [195] Ozcan O, Uyar A, Doruker P, et al. (2013) Effect of Intracellular Loop 3 on Intrinsic Dynamics of Human β2-Adrenergic Receptor. BMC Struct Biol 13: 29. https://doi.org/10.1186/1472-6807-13-29
    [196] Matsuo T (2021) Viewing SARS-CoV-2 nucleocapsid protein in terms of molecular flexibility. Biology (Basel) 10: 454. https://doi.org/10.3390/biology10060454
    [197] Gordon CJ, Tchesnokov EP, Woolner E, et al. (2020) Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. J Biol Chem 295: 6785-6797. https://doi.org/10.1074/jbc.RA120.013679
    [198] Mahmud S, Biswas S, Paul GK, et al. (2021) Plant-based phytochemical screening by targeting main protease of SARS-CoV-2 to design effective potent inhibitors. Biology (Basel) 10: 589. https://doi.org/10.3390/biology10070589
    [199] Arooj M, Shehadi I, Nassab CN, et al. (2022) Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets. Chem Zvesti 76: 111-121. https://doi.org/10.1007/s11696-021-01843-0
    [200] Bhattacharjee S, Bhattacharyya R, Sengupta J (2021) Dynamics and electrostatics define an allosteric druggable site within the receptor-binding domain of SARS-CoV-2 spike protein. FEBS Lett 595: 442-451. https://doi.org/10.1002/1873-3468.14038
    [201] Kern P, Hemmer CJ, Damme JV, et al. (1989) Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated plasmodium falciparum malaria. Am J Med 87: 139-143. https://doi.org/10.1016/s0002-9343(89)80688-6
    [202] Danlos FX, Ackermann F, Rohmer J, et al. (2021) High levels of TNFα in patients with COVID-19 refractory to tocilizumab. Eur J Cancer 149: 102-104. https://doi.org/10.1016/j.ejca.2021.01.056
    [203] Halim SA, Sikandari AG, Khan A, et al. (2021) Structure-based virtual screening of tumor necrosis factor-α inhibitors by cheminformatics approaches and bio-molecular simulation. Biomolecules 11: 329. https://doi.org/10.3390/biom11020329
    [204] Fernández PV, Quintana I, Cerezo AS, et al. (2013) Anticoagulant activity of a unique sulfated pyranosic (1→3)-β-l-arabinan through direct interaction with thrombin. J Biol Chem 288: 223-233. https://doi.org/10.1074/jbc.M112.386441
    [205] Likić VA, Gooley PR, Speed TP, et al. (2005) A statistical approach to the interpretation of molecular dynamics simulations of calmodulin equilibrium dynamics. Protein Sci 14: 2955-2963. https://doi.org/10.1110/ps.051681605
    [206] Hu K, Yao X (2002) Protodioscin (NSC-698 796): Its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel. Planta Med 68: 297-301. https://doi.org/10.1055/s-2002-26743
    [207] Shen J, Yang X, Meng Z, et al. (2016) Protodioscin ameliorates fructose-induced renal injury via inhibition of the mitogen activated protein kinase pathway. Phytomedicine 23: 1504-1510. https://doi.org/10.1016/j.phymed.2016.08.009
    [208] Zhang X, Xue X, Xian L, et al. (2016) Potential neuroprotection of protodioscin against cerebral ischemia-reperfusion injury in rats through intervening inflammation and apoptosis. Steroids 113: 52-63. https://doi.org/10.1016/j.steroids.2016.06.008
    [209] Oyama M, Tokiwano T, Kawaii S, et al. (2017) Protodioscin, isolated from the rhizome of dioscorea tokoro collected in northern Japan is the major antiproliferative compound to HL-60 leukemic cells. Curr Bioact Compd 13: 170-174. https://doi.org/10.2174/1573407213666170113123428
    [210] Bagchi D, Swaroop A, Maheshwari A, et al. (2017) A novel protodioscin-enriched fenugreek seed extract (Trigonella foenum-graecum, family Fabaceae) improves free testosterone level and sperm profile in healthy volunteers. Funct Foods Health Dis 7: 235-245. https://doi.org/10.31989/ffhd.v7i4.326
    [211] Wu J, Zhao YM, Deng ZK (2018) Neuroprotective action and mechanistic evaluation of protodioscin against rat model of Parkinson's disease. Pharmacol Rep 70: 139-145. https://doi.org/10.1016/j.pharep.2017.08.013
    [212] Harmayani E, Anal AK, Wichienchot S, et al. (2019) Healthy food traditions of Asia: exploratory case studies from Indonesia, Thailand, Malaysia, and Nepal. J Ethn Food 6: 1. https://doi.org/10.1186/s42779-019-0002-x
    [213] Tietze HW (2006) Papaya the medicine tree.Harald Tietze Publishing.
  • molsci-10-03-015-s001.pdf
  • This article has been cited by:

    1. Andreas Se Ho Kugele, Biswajit Sarkar, Reducing carbon emissions of a multi-stage smart production for biofuel towards sustainable development, 2023, 70, 11100168, 93, 10.1016/j.aej.2023.01.003
    2. Zahra Davoudi, Mehdi Seifbarghy, Mitali Sarkar, Biswajit Sarkar, Effect of bargaining on pricing and retailing under a green supply chain management, 2023, 73, 09696989, 103285, 10.1016/j.jretconser.2023.103285
    3. Shiv Raj Singh, Mitali Sarkar, Biswajit Sarkar, Effect of Learning and Forgetting on Inventory Model under Carbon Emission and Agile Manufacturing, 2023, 11, 2227-7390, 368, 10.3390/math11020368
    4. Dharmendra Yadav, Umesh Chand, Ruchi Goel, Biswajit Sarkar, Smart Production System with Random Imperfect Process, Partial Backordering, and Deterioration in an Inflationary Environment, 2023, 11, 2227-7390, 440, 10.3390/math11020440
    5. Taniya Mukherjee, Isha Sangal, Biswajit Sarkar, Qais Ahmed Almaamari, Logistic models to minimize the material handling cost within a cross-dock, 2022, 20, 1551-0018, 3099, 10.3934/mbe.2023146
    6. Mitali Sarkar, Yong Won Seo, Biodegradable waste to renewable energy conversion under a sustainable energy supply chain management, 2023, 20, 1551-0018, 6993, 10.3934/mbe.2023302
    7. Soumya Kanti Hota, Biswajit Sarkar, Santanu Kumar Ghosh, Naoufel Cheikhrouhou, Gerardo Treviño-Garza, What should be the best retail strategy to deal with an unequal shipment from an unreliable manufacturer?, 2024, 76, 09696989, 103576, 10.1016/j.jretconser.2023.103576
  • Reader Comments
  • © 2023 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2000) PDF downloads(168) Cited by(2)

Figures and Tables

Figures(13)  /  Tables(7)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog